The Neurology of Olfaction


The Neurology of Olfaction

Testing the sense of smell is often omitted or trivialized during neurological examination. This comprehensive review will address this shortcoming by emphasizing the significance of this important sensory modality. The Neurology of Olfaction describes the anatomy and physiology of human olfaction and how it may be measured. The book covers neurologic disorders in depth and a comprehensive chapter is devoted to neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease, where loss of smell is frequent and may be an early preclinical feature that could predict the onset of disease in asymptomatic subjects. Finally, the authors describe methods of treatment for anosmia, evaluate its medicolegal importance, and give guidance for those unfortunate enough to have lost their sense of smell. Written by two experts in the field, this book provides information useful to physicians for assessing and managing chemosensory disorders and summarizes the current scientific knowledge of human olfaction.


 Reviews:

"This book on olfaction fills a definite void in the literature. The authors are correct in noting that olfaction is overlooked in diagnosis and therapy. Their book will help readers refocus on the importance of testing for disorders of olfaction. I can easily see any clinical neurologist, neurology resident, fellow, or medical student using this book to gain a better understanding of this sense."
--Doody's Review Service

'This book on olfaction fills a definite void in the literature.' Doody's

Abele M, Riet A, Hummel T, Klockgether T, Wullner U. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. Journal of Neurology 2003, 250, 1453–5.
Acharya V, Acharya J and Luders H. Olfactory epileptic auras. Neurology, 1998, 51(1), 56–6.
Ache BW and Restrepo D. Olfactory transduction. In TE Finger, WL Silver, and D Restrepo, eds. The Neurobiology of Taste and Smell. New York, NY: Wiley–Liss, 2000, p. 159–77.
Adler CH, Caviness JN, Sabbagh MN, Hentz JG, Evidente V and Shill H. Olfactory testing in Parkinson's disease and other movement disorders: correlation with Parkinsonian severity. Movement Disorders, 2005, 20(Suppl. 10), Abs. 231.
Adrian ED. Olfactory reactions in the brain of the hedgehog. Journal of Physiology, 1942, 100, 459–73.
Aggarwal NT, Bienias JL, Bennett DA et al. The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology, 2006, 26(3), 140–6.
Ahlskog JE, Waring SC, Petersen RC et al. Olfactory dysfunction on Guamanian ALS parkinsonism and dementia. Neurology, 1998, 51, 1672–7.
Air Force Instructions 48–123. Accession, retention and administration. Medication Examination and Standards, 2, 5 June 2006.
Akerlund A, Bende M and Murphy C. Olfactory threshold and nasal mucosal changes in experimentally induced common cold. Acta Otolaryngologica, 1995, 115, 88–92.
Albone ES. Mammalian Semiochemistry. New York, NY: John Wiley & Sons, 1984.
Alobid I, Guilemany JM and Mullol J. Nasal manifestations of systemic illnesses. Current Allergy and Asthma Reports, 2004, 4(3), 208–16.
Altman, J. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. Journal of Comparative Neurology, 1969, 137, 433–57.
Amoore JE and Ollman BG. Practical test kits for quantitatively evaluating the sense of smell. Rhinology, 1983, 21, 49–54.
Amoore JE and Steinle S. A graphical history of specific anosmia. In: CJ Wysocki and MR Kare, eds., Chemical Senses. Volume 3. Genetics of Perception and Communications. New York, NY: Marcel Dekker, Inc., 1991, Chapter 23.
Amoore JE. Effects of chemical exposure on olfaction in humans. In: CS Barrow, ed., Toxicology of the Nasal Passages. Washington, DC: Hemisphere Publishing, 1986, pp. 155–90.
Amoore JE. Specific anosmia: a clue to the olfactory code. Nature, 1967, 214(5093), 1095–8.
Amsterdam JD, Settle RG, Doty RL, Abelman E and Winokur A. Taste and smell perception in depression. Biological Psychiatry, 1987, 22(12), 1481–5.
Anderson AK, Christoff K, Stappen I et al. Dissociated neural representations of intensity and valence in human olfaction. Nature and Neuroscience, 2003, 6(2), 196–202.
Anderson GBJ and Cocchiarella L. Guides to the Evaluation of Permanent Impairment, 6th edn. Chicago, IL: American Medical Association Press, 1995.
Anholt RR. Molecular physiology of olfaction. American Journal of Physiology, 1989, 257, C1043–54.
Ansari KA and Johnson AJ. Olfactory function in patients with Parkinson's disease. Journal of Chronic Diseases, 1975, 28, 493–7.
Ansari KA Olfaction in multiple sclerosis. European Neurology, 1976, 14, 138–45.
Antunes M, Bowler RM and Doty RL. San Francisco/Oakland Bay Bridge Welder Study: olfactory function. Neurology, 2007, 69(12), 1278–84.
Antunes M, Bowler RM and Doty RL. San Francisco/Oakland Bay Bridge Welder Study: olfactory function. Neurology, 2007, 69(12), 1278–84.
Arden MA and Dye L. The assessment of menstrual synchrony: comment on Weller and Weller (1997). Journal of Comparative Psychology, 1998, 112, 323–4.
Aronsohn E. Experimentalle Untersuchungen zur Physiologie des Geruchs. Archiv Physiol. Leipzig, 1886, 321–57.
Aronzon A, Hanson CW and Thaler ER. Differentiation between cerebrospinal fluid and serum with electronic nose. Otolaryngology – Head and Neck Surgery, 2005, 133(1), 16–19.
Arriagada PV, Louis DN, Hedley-Whyte ET and Hyman BT. Neurofibrillary tangles and olfactory dysgenesis. Lancet, 1991, 337(8740), 559.
Ascherio A, Chen H, Weisskopf MG et al. Pesticide exposure and risk for Parkinson's disease. Annals of Neurology, 2006, 60(2), 197–203.
Bacon AW, Bondi MW, Salmon DP and Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Annals of the New York Acadamy of Sciences, 1998, 855, 723–31.
Baird JC, Lewis C and Romer D. Relative frequencies of numerical responses in ratio estimation. Perception and Psychophysics, 1970, 8, 358–62.
Baker H and Genter MB. The olfactory system and the nasal mucosa as portals of entry of viruses, drugs, and other exogenous agents into the brain. In: RL Doty, ed., Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 549–73.
Baker KB and Montgomery EB Jr. Performance on the PD test battery by relatives of patients with progressive supranuclear palsy. Neurology, 2001, 56(1), 25–30.
Ball M J and Nuttall K. Neurofibrillary tangles granulovacuolar degeneration and neuron loss in Down's syndrome: quantitative comparison with Alzheimer's dementia. Annals of Neurology, 1980, 7, 462–5.
Ballard C, Ziabreva I, Perry R et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology, 2006, 67(11), 1931–4.
Bang F, Bang B and Foard M. Responses of upper respiratory mucosa to drugs and viral infections. American Review of Respiratory Disease, 1966, 93, 5142–9.
Barnett EM, Cassell MD and Perlman S. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience, 1993, 57(4), 1007–25.
Bartosik-Psujek H, Psujek M and Stelmasiak Z. Rare first symptoms of multiple sclerosis. Annales Universitatis Mariae Curie-Sklodowska, Sectio D, Medicina, 2004, 59(1), 242–4.
Barz S, Hummel T, Pauli E, Majer M, Lang CJ and Kobal G. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in Parkinson's disease. Neurology, 1997, 49, 1424–31.
Baylis LL, Rolls ET and Baylis GC. Afferent connections of the caudolateral orbitofrontal cortex taste area of the primate. Neuroscience, 1995, 64(3), 801–12.
Bedard A and Parent A. Evidence of newly generated neurons in the human olfactory bulb. Brain Research, Developmental Brain Research, 2004, 151(1–2), 159–68.
Berger PC and Vogel FS. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. American Journal of Pathology, 1973, 73, 457–76.
Berglund H, Lindstrom P and Savic I. Brain response to putative pheromones in lesbian women. Proceedings of the National Academy of Science of the United States of America, 2006, 103(21), 8269–74.
Betarbet R, Sherer TB, MacKenzie G et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neuroscience, 2000, 3, 1301–6.
Bethe A. Vernachlässigte hormone. Naturwissenschaften, 1932, 11, 177–81.
Betts T. Use of aromatherapy (with or without hypnosis) in the treatment of intractable epilepsy – a two-year follow-up study. Seizure, 2003, 12(8), 534–8.
Bhatnagar KP, Smith TD, Winstead W, Bhatnagar KP, Smith TD and Winstead W. The human vomeronasal organ: part IV. Incidence, topography, endoscopy, and ultrastructure of the nasopalatine recess, nasopalatine fossa, and vomeronasal organ. American Journal of Rhinology, 2002, 16, 343–50.
Blacque OE and Leroux MR. Bardet–Biedl syndrome: an emerging pathomechanism of intracellular transport. Cellular and Molecular Life Sciences, 2006, 63(18), 2145–61.
Blau JN and Solomon F. Smell and other sensory disturbances in migraine. Journal of Neurology, 1985, 232(5), 275–6.
Boesveldt S, Verbaan D, Knol DL, van Hilten JJ and Berendse HW. Assessment of odor identification and discrimination in Dutch Parkinson's disease patients. Movement Disorders, 2007, 22(Suppl. 16), S161 (abstract).
Boeve BF, Silber MH and Parisi JE et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology, 2003, 61(1), 40–5.
Bohnen NI, Gedela S and Kuwabara H et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. Journal of Neurology, 2007, 254(1), 84–90.
Bomback A. The physical exam and the sense of smell. New England Journal of Medicine, 2006, 354(4), 327–9.
Bond JA. Bioactivation and biotransformation of xenobiotics in rat nasal tissue. In: CS Barrow, ed. Toxicology of the Nasal Passages. Washington, DC: Hemisphere Publishing Corporation, 1986, pp. 249–61.
Bond JA. Bioactivation and biotransformation of xenobiotics in rat nasal tissue. In: CS Barrow, ed., Toxicology of the Nasal Passages. Washington, DC: Hemisphere Publishing Corporation, 1986, pp. 249–61.
Bostantjopoulou S, Katsarou Z, Papadimitriou A, Veletza V, Hatzigeorgiou G and Lees A. Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Movement Disorders, 2001, 16(6), 1007–13.
Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE and Rocca WA. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology, 2006; 67, 494–6.
Braak H and Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. Journal of Neural Transmission. Supplementum, 1998, 53, 127–40.
Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH and Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's diseases. Journal of Neural Trans, 1996, 103, 455–90.
Braak H, de Vos RAI, Bohl J and Del Tredici K. Gastric-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neuroscience Letters, 2006, 396, 67–72.
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 2003a, 24, 197–211.
Braak H, Ghebremedhin E, Rüb U, Bratzke H and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Research, 2004, 318(1), 121–34.
Braak H, Rub U, Gai WP and Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission, 2003b, 110(5), 517–36.
Breer H and Boekhoff I. Second messenger signalling in olfaction. Current Opinion in Neurobiology, 1992, 2, 439–43.
Breer H. Sense of smell: recognition and transduction of olfactory signals. Biochemical Society Transactions, 2003, 31, 113–16.
Brewer WJ, Wood SJ, McGorry PD et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. American Journal of Psychiatry, 2003, 160(10), 1790–4.
Briggs MH and Duncan RB. Odor receptors. Nature, 1961, 91, 1310–11.
Brittebo EB, Eriksson VF, Bakke J and Brandt I. Toxicity of 2 6-dichlorothiobenzamide (Chlorthiamid) and 2 6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundamental and Applied Toxicology, 1991, 17, 92–102.
Brittebo EB, Eriksson VF, Bakke J, and Brandt I. Toxicity of 2,6-dichlorothiobenzamide (Chlorthiamid) and 2,6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundamental and Applied Toxicology, 1991, 17: 92–102.
Brousseau K and Brainerd HG. Mongolism: A Study of the Physical and Mental Characteristics of Mongolian Imbeciles. Baltimore, MD: Williams & Wilkins, 1928.
Brown KS, MacLean CM and Robinette RR. The distribution of the sensitivity to chemical odors in man. Human Biology, 1968, 40, 456–72.
Brownstein D. Resistance/susceptibility to lethal Sendai virus infection generally linked to a mucociliary transport polymorphism. Journal of Virology, 1987, 61, 1670–1.
Bruch RC. Signal transducing GTP-binding proteins in olfaction. Comparative Biochemistry and Physiology, 1990, 95A, 27–9.
Bryant B and Silver WL. Chemesthesis: the common chemical sense. In: TE Finger, WL Silver and D Restrepo, eds. The Neurobiology of Taste and Smell (2nd edition). New York, NY: Wiley–Liss, 2000, p. 73.
Buchanan TW, Tranel D and Adolphs R. A specific role for the human amygdala in olfactory memory. Learning and Memory, 2003, 10(5), 319–25.
Buchanan TW, Tranel D and Adolphs R. A specific role for the human amygdala in olfactory memory. Learning and Memory, 2003, 10(5), 319–25.
Buchel C, Morris J, Dolan RJ and Friston KJ. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron, 1998, 20(5), 947–57.
Buck L and Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell, 1991, 65, 175–87.
Burdach KJ and Doty RL. The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiology and Behavior, 1987, 41, 353–6.
Burdach KJ and Doty RL. The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiology and Behavior, 1987, 41, 353–6.
Busenbark KL, Huber SJ, Greer G, Pahwa R and Koller WC. Olfactory function in essential tremor. Neurology, 1992, 42, 1631–2.
Buttery RG, Teranishi R, Ling LC and Turnbaugh JG. Quantitative and sensory studies on tomato paste volatiles. Journal of Agricultural and Food Chemistry, 1990, 38, 336–40.
Buxton PH and Hayward M. Polyneuritis cranialis associated with industrial trichloroethylene exposure. Journal of Neurology Neurosurgery and Psychiatry, 1967, 30, 511–18.
Bylsma FW, Moberg PJ, Doty RL and Brandt J. Odor identification in Huntington's disease patients and their offspring with and without the genetic mutation for HD. Journal of Neuropsychiatry and Clinical Neuroscience, 1997, 9, 598–60.
Cain WS, Gent J, Catalanotto FA. and Goodspeed RB. Clinical evaluation of olfaction. American Journal of Otolaryngology, 1983, 4, 252–6.
Calderón-Garcidueñas L, Franco-Lira M, Doty RL et al. Olfactory epithelium and olfactory bulb pathology in urban air pollution exposed dogs and humans: the pathological bases for olfactory deficits in exposed young healthy adults. (in press)
Calderón-Garcidueñas L, Reed W, Maronpot RR et al. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicologic Pathology, 2004, 32, 650–8.
Cameron EL. Measures of human olfactory perception during pregnancy. Chemical Senses, 2007, 32, 775–82.
Cameron EL. Measures of human olfactory perception during pregnancy. Chemical Senses, 2007, 32, 775–82.
Carrasco M and Ridout JB. Olfactory perception and olfactory imagery: a multidimensional analysis. Journal of Experimental Psychology: Human Perception and Performance, 1993, 19, 287–301.
Carroll B, Richardson JT and Thompson P. Olfactory information processing and temporal lobe epilepsy. Brain and Cognition, 1993, 22(2), 230–43.
Chabaud P, Ravel N, Wilson DA et al. Exposure to behaviorally relevant odor reveals differential characteristics in rat central olfactory pathways as studied through oscillatory activities. Chemical Senses, 2000, 25(5), 561–73.
Chabolla DR. Characteristics of the epilepsies. Mayo Clinic Proceedings, 2002, 77, 981–90.
Chalke HD and Dewhurst JR. Loss of smell in old people. Public Health, 1956, 72, 223.
Charles PC, Walters E, Margolis F and Johnston RE. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology, 1995, 208, 662–71.
Cheeseman GH and Kirkby HM. An air dilution olfactometer suitable for group threshold measurements. Quarterly Journal of Experimental Physiology, 1959, 11, 115–23.
Cheeseman GH and Townsend MJ. Further experiments on the olfactory thresholds of pure chemical substances using the “sniff-bottle method”. Quarterly Journal of Experimental Psychology, 1956, 8, 8–14.
Chen C, Shih YH, Yen DJ et al. Olfactory auras in patients with temporal lobe epilepsy. Epilepsia, 2003, 44(2), 257–60.
Chitanondh H. Stereotaxic amygdalotomy in the treatment of olfactory seizures and psychiatric disorders with olfactory hallucination. Confinia Neurologica, 1966, 27(1), 181–96.
Choudhury ES, Moberg P and Doty RL. Influences of age and sex on a microencapsulated odor memory test. Chemical Senses, 2003, 28, 799–805.
Chuah MI, Schwob JE and Farbman AI. Developmental anatomy of the olfactory system. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 115–38.
Claus R and Hoppen HO. The boar-pheromone steroid identified in vegetables. Experientia, 1979, 35, 1674–5.
Cometto-Muniz JE and Cain WS. Olfactory adaptation. In: RL Doty, ed. Handbook of Olfaction and Gustation (1st edition). New York, NY: Marcel Dekker, 1995, pp. 257–81.
Connelly T, Farmer JM, Lynch DR and Doty RL. Olfactory dysfunction in degenerative ataxias. Journal of Neurology, Neurosurgery and Psychiatry, 2003, 74(10), 1435–7.
Constantinescu CS, Raps EC, Cohen JA, West SE and Doty RL. Olfactory disturbances as the initial or most prominent symptom of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 1994, 57(8), 1011–2.
Coopersmith R, Henderson SR and Leon M. Odor specificity of the enhanced neural response following early odor experience in rats. Brain Research, 1986, 392, 191–7.
Cornsweet TN. The staircase-method in psychophysics. American Journal of Psychology, 1962, 75, 485–91.
Correia S, Faust D and Doty RL. A re-examination of the rate of vocational dysfunction among patients with anosmia and mild/moderate closed head injury. Journal of Clinical and Experimental Neuropsychology, 2000, 15, 1–12.
Costanzo RM, DiNardo LJ and Zasler ND. Head injury and olfaction. In: RL Doty, ed., Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, Inc., 1995, pp. 629–38.
Covington JW, Geisler MW, Polich J and Murphy C. Normal aging and odor intensity effects on the olfactory event-related potential. International Journal of Psychophysiology, 1999, 32, 205–14.
Crino PB, Martin JA, Hill WD, Greenberg B, Lee VM and Trojanowski JQ. Beta-amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease Parkinson's disease and Down syndrome. Annals of Otology, Rhinology and Laryngology, 1995, 104, 655–61.
Critchley M. The citadel of the senses: the nose as its sentinel. In: M Critchley, ed. The Citadel of the Senses. New York, NY: Raven Press, 1986, pp. 1–14.
Cuestas E, Busso R, Barcudi S and Tapia N. A case of a child with bad odor. Medicina, 2005, 65(4), 341–4.
Dade LA, Zatorre RJ and Jones-Gotman M. Olfactory learning: convergent findings from lesion and brain imaging studies in humans. Brain, 2002, 125, 86–101.
Dahl AR. Possible consequences of cytochrome P-450 dependent monooxygenases in nasal tissues. In: CS Barrow, ed. Toxicology of the Nasal Passages. Washington, DC: Hemisphere Publishing Corporation, 1986, pp. 263–73.
Dahl AR. Possible consequences of cytochrome P-450 dependent monooxygenases in nasal tissues. In: CS Barrow, ed., Toxicology of the Nasal Passages. Washington, DC: Hemisphere Publishing Corporation, 1986, pp. 263–73.
Dahl AR. The effect of cytochrome P-450-dependent metabolism and other enzyme activities in olfaction. In: FL Margolis and TV Getchell, eds. Molecular Neurobiology of the Olfactory System. New York, NY: Plenum Press, 1988, pp. 51–70.
Dahl AR. The effect of cytochrome P-450-dependent metabolism and other enzyme activities in olfaction. In: FL Margolis and TV Getchell, eds. Molecular Neurobiology of the Olfactory System. New York, NY: Plenum Press, 1988, pp. 51–70.
Damm M, Eckel HE, Jungehulsing M and Hummel T. Olfactory changes at threshold and suprathreshold levels following septoplasty with partial inferior turbinectomy. Annals of Otology, Rhinology & Laryngology, 2003, 112, 91–7.
Daniel SE and Hawkes CH. Preliminary diagnosis of Parkinson's disease using olfactory bulb pathology. Lancet, 1992, 340, 186 (letter).
Daniels C, Gottwald B, Pause BM, Sojka B, Mehdorn HM and Ferstl R. Olfactory event-related potentials in patients with brain tumors. Clinical Neurophysiology, 2001, 112(8), 1523–30.
Daum RF, Sekinger B, Kobal G and Lang CJ. Olfactory testing with “sniffin' sticks” for clinical diagnosis of Parkinson disease. Nervenarzt, 2000, 71, 643–50.
Davidson TM and Murphy C. Rapid clinical evaluation of anosmia. The alcohol sniff test. Archives of Otolaryngology, Head and Neck Surgery, 1997, 123: 591–4.
Davila NG, Blakemore LJ and Trombley PQ. Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. Journal of Neurophysiology, 2003, 90, 395–404.
Davis RG. Acquisition and retention of verbal associations to olfactory and abstract visual stimuli of varying similarity. Journal of Experimental Psychology: Human Learning and Memory, 1977, 3, 37–51.
de Morsier, G. Median cranioencephalic dysraphias and olfactogenital dysplasia. World Neurology, 1962, 3, 485–506.
Deeb J, Findley LJ, Shah M, Muhammed N and Hawkes CH. Smell tests compared to dopamine transporter imaging in diagnosis of idiopathic parkinson's disease: a pilot study. Journal of Neurology Neurosurgery and Psychiatry, 2006, 77, 127 (P014).
Deems DA, Doty RL and Settle RG et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Archives of Otolaryngology, Head, and Neck Surgery, 1991, 117(5), 519–28.
Deems DA, Doty RL, Settle RG et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Archives of Otolaryngology, Head and Neck Surgery, 1991, 117, 519–28.
Del Tredici K and Braak H. Idiopathic Parkinson's disease: staging an-synucleinopathy with a predictable pathoanatomy. In: P Kahle and C Haass, eds, Molecular Mechanisms in Parkinson's Disease. Georgetown, TX: Landes Bioscience, 2004, pp. 1–32.
Delank KW and Fechner G. Pathophysiology of post-traumatic anosmia. Laryngorhinootologie, 1996, 75(3), 154–9.
Devanand DP, Michaels-Marston KS, Liu X et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. American Journal of Psychiatry, 2000, 157, 1399–405.
Di Nardo W, Di Girolamo W, Galli A, Meduri G, Paludetti G and De Rossi G. Olfactory function evaluated by SPECT. American Journal of Rhinology, 2000, 14, 57–61.
Diaz-Maroto MC, Perez-Coello MS and Cabezudo MD. Headspace solid-phase microextraction analysis of volatile components of spices. Chromatographia, 2002, 55, 723–8.
Ding X and Coon MJ. Immunochemical characterisation of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue specific expression of P-450s NMa and NMb. Cellular Pharmacology, 1990, 37, 489–96.
Ding X and Coon MJ. Immunochemical characterisation of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue specific expression of P-450s NMa and NMb. Cellular Pharmacology, 1990, 37, 489–96.
Ding X and Dahl AR. Olfactory mucosa: composition, enzymatic localization, and metabolism. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 51–73.
Donchin E and Coles MGH. Is the P300 a manifestation of context updating? Behavioral and Brain Sciences, 1988, 11, 357–428.
Doty RL and Bromley SM. Effects of drugs on olfaction and taste. Otolaryngologic Clinics of North America, 2004, 37(6), 1229–54.
Doty RL and Bromley SM. Olfaction and taste. In: A Crockard, R Hayward and JT Hoff, eds. Neurosurgery: The Scientific Basis of Clinical Practice. London: Blackwell Science, 2000, pp. 347–65.
Doty RL and Cometto-Muniz JE. Trigeminal chemosensation. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 981–99.
Doty RL and Frye R. Influence of nasal obstruction on smell function. Otolaryngologic Clinics of North America, 1989, 22(2), 397–411.
Doty RL and Hastings L. Neurotoxic exposure and olfactory impairment. Clinics in Occupational and Environmental Medicine, 2001, 1, 547–75.
Doty RL and Haxel BR. Objective assessment of terbinafine-induced taste loss. Laryngoscope, 2005, 115, 2035–7.
Doty RL and Izhar M. Can influence vaccinations after smell function? Unpublished manuscript.
Doty RL and Kerr KL. Episodic odor memory: influences of handedness, sex, and side of nose. Neuropsychologia, 2005, 43, 1749–53.
Doty RL and Laing DG. Psychophysical measurement of olfactory function, including odorant mixture assessment. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 203–28.
Doty RL, Applebaum S, Zusho H and Settle RG. Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia, 1985, 23, 667–72.
Doty RL, Brugger WE, Jurs PC, Orndorff MA, Snyder PJ and Lowry LD. Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiology and Behavior, 1978, 20, 175–85.
Doty RL, Cometto-Muniz JE, Jalowayski AA, Dalton P, Kendal-Reed M and Hodgson M. Assessment of upper respiratory tract and ocular irritative effects of volatile chemicals in humans. Critical Reviews in Toxicology, 2004, 34, 85–142.
Doty RL, Deems DA and Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs disease stage or disease duration. Neurology, 1988, 38, 1237–44.
Doty RL, Deems DA, Frye RE, Pelberg R and Shapiro A. Olfactory sensitivity nasal resistance and autonomic function in patients with multiple chemical sensitivities. Archives of Otolaryngology, Head, and Neck Surgery, 1988, 114, 1422–7.
Doty RL, Deems DA, Frye RE, Pelberg R and Shapiro A. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Archives of Otolaryngology, Head and Neck Surgery, 1988, 114, 1422–7.
Doty RL, Fernandez AD, Levine MA, Moses A and McKeown DA. Olfactory dysfunction in type I pseudohypoparathyroidism: dissociation from Gs alpha protein deficiency. Journal of Clinical Endocrinology and Metabolism, 1997c, 82(1), 247–50.
Doty RL, Genow A and Hummel T. Scratch density differentiates microsmic from normosmic and anosmic subjects on the University of Pennsylvania Smell Identification Test. Perceptual and Motor Skills, 1998, 86, 211–16.
Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM and Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's Disease. Neurology, 1993, 43, 962–5.
Doty RL, Gregor TP and Settle RG. Influence of intertrial interval and sniff-bottle volume on phenyl ethyl alcohol odor detection thresholds. Chemical Senses, 1986, 11, 259–64.
Doty RL, Kreiss DS and Frye RE. Human odor intensity perception: correlation with frog epithelial adenylate cyclase activity and transepithelial voltage response. Brain Research, 1990, 527, 130–4.
Doty RL, Li C, Mannon LJ and Yousem DM. Olfactory dysfunction in multiple sclerosis. New England Journal of Medicine, 1997a, 336(26), 1918–19.
Doty RL, Li C, Mannon LJ and Yousem DM. Olfactory dysfunction in multiple sclerosis. Relation to plaque load in inferior frontal and temporal lobes. Annals of the New York Academy of Sciences, 1998b, 30(855), 781–6.
Doty RL, Li C, Mannon LJ and Yousem DM. Olfactory dysfunction in multiple sclerosis: relation to longitudinal changes in plaque numbers in central olfactory structures. Neurology, 1998a, 53(4), 880–2.
Doty RL, Marcus A and Lee WW. Development of the 12-item cross-cultural smell identification test (CC-SIT). Laryngoscope, 1996, 106, 353–6.
Doty RL, McKeown DA, Lee WW and Shaman P. A study of the test–retest reliability of ten olfactory tests. Chemical Senses, 1995, 20(6), 645–56.
Doty RL, Perl DP, Steele JC et al. Odor identification deficit of the parkinsonism–dementia complex of Guam: equivalence to that of Alzheimer's disease and idiopathic Parkinson's disease. Neurology, 1991, 41(Suppl. 2), 77–81.
Doty RL, Philip S, Reddy K and Kerr K-L. Influences of antihypertensive and antihyperlipid-emic drugs on the senses of taste and smell: a review. Journal of Hypertension, 2003, 21, 1805–13.
Doty RL, Reyes PF and Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin, 1987, 18, 597–600.
Doty RL, Reyes PF and Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin, 1987, 18, 597–600.
Doty RL, Riklan M, Deems DA, Reynolds C and Stellar S. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Annals of Neurology, 1989, 25, 166–71.
Doty RL, Shah M and Bromley SM. Drug-induced taste disorders: incidence, prevention and management. Drug Safety, 2008, 31, 199–215.
Doty RL, Shaman P and Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiology and Behavior, 1984, 32, 489–502.
Doty RL, Shaman P and Dann M. Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test olfactory function. Physiology and Behavior, 1984; 32, 489–502 (monograph).
Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L and Rosenberg L. Smell identification ability: changes with age. Science, 1984, 226(4681), 1441–3.
Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L and Rosenberg L. Smell identification ability: changes with age. Science, 1984, 226, 1441–3.
Doty RL, Singh A, Tetrud J and Langston JW. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Annals of Neurology, 1992b, 32, 87–100.
Doty RL, Smith R, McKeown DA and Raj J. Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance. Perception and Psychophysics, 1994, 56(6), 701–7.
Doty RL, Smith R, McKeown DA and Raj J. Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance. Perception and Psychophysics, 1994, 56, 701–7.
Doty RL, Snyder PJ, Huggins GR and Lowry LD. Endocrine, cardiovascular, and psychological correlates of olfactory sensitivity changes during the human menstrual cycle. Journal of Comparative Physiology and Psychology, 1981, 95(1), 45–60.
Doty RL, Snyder PJ, Huggins GR and Lowry LD. Endocrine, cardiovascular, and psychological correlates of olfactory sensitivity changes during the human menstrual cycle. Journal of Comparative Physiology and Psychology, 1981, 95, 45–60.
Doty RL, Snyder PJ, Huggins GR and Lowry LD. Endocrine, cardiovascular, and psychological correlates of olfactory sensitivity changes during the human menstrual cycle. Journal of Comparative Physiology and Psychology, 1981, 95, 45–60.
Doty RL, Stern MB, Pfeiffer C, Gollomp SM and Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 1992a, 55, 138–42.
Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R and Lee WW. Olfactory dysfunction in patients with head trauma. Archives of Neurology, 1997, 54(9), 1131–40.
Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R and Lee WW. Olfactory dysfunction in patients with head trauma. Archives of Neurology, 1997b, 54, 1131–40.
Doty RL. An examination of relationships between the pleasantness, intensity, and concentration of 10 odorous stimuli. Perception and Psychophysics, 1975, 17, 492–6.
Doty RL. Introduction and historical perspective. In: RL Doty, ed., Handbook of Olfaction and Gustation (second edition). New York, NY: Marcel Dekker, 2003b, pp. xv–xiv.
Doty RL. Mammalian pheromones: fact or fantasy? In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 345–83.
Doty RL. Odor perception in neurodegenerative disease. In: RL Doty, ed., Handbook of Olfaction and Gustation (second edition). New York, NY: Marcel Dekker, 2003a, Chapter 23.
Doty RL. Office procedures for quantitative assessment of olfactory function. American Journal of Rhinology, 2007, 21, 460–73.
Doty RL. Olfaction. Annual Review of Psychology, 2001, 52, 423–52.
Doty RL. Olfaction. Annual Review of Psychology, 2001, 52, 423–52.
Doty RL. Olfactory dysfunction in neurodegenerative disorders. In: TV Getchell, RL Doty, LM Bartoshuk and JB Snow Jr (eds), Smell and Taste in Health and Disease. New York, NY: Raven Press, 1991, pp. 735–50.
Doty RL. The Odor Memory Test™ Administration Manual. Haddon Hts., NJ: Sensonics, Inc., 2003.
Doty RL. The Odor Threshold Test™ Administration Manual. Haddon Hts., NJ: Sensonics, Inc., 2000.
Doty RL. The olfactory vector hypothesis of neurodegenerative disease: is it viable? Annals of Neurology, 2008, 63, 7–15.
Doty RL. The Smell Identification Test™ Administration Manual (3rd edition). Haddon Hts., NJ: Sensonics, Inc., 1995.
Double KL, Rowe DB, Hayes M et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Archives of Neurology, 2003, 60, 545–9.
Drake B, Johansson B, von Sydow D and Doving KB. Quantitative psychophysical and electrophysiological data on some odorous compounds. Scandinavian Journal of Psychology, 1969, 10, 89–96.
Duda JE, Noorigian JV, Petrovitch H, White LR and Ross WR. Pattern of Lewy body progression suggested Braak staging system is supported by analysis of a population based cohort of patients. Movement Disorders, 2007, 22 (Suppl. 16), LB5 (late-breaking abstract).
Duda JE, Shah U, Arnold SE, Lee VM and Trojanowski JQ. The expression of alpha- beta- and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Experimental Neurology, 1999, 160, 515–22.
Duff K, McCaffrey RJ and Solomon GS. The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 2002, 14, 197–201.
Duncan HJ and Smith DV. Clinical disorders of olfaction. In: RL Doty, ed., Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker Inc., 1995, pp. 345–66.
Duncan RB and Briggs MH. Treatment of uncomplicated anosmia by vitamin A. Archives of Otolaryngology, 1962, 75, 116–24.
Dunn LM. Peabody Picture Vocabulary Test – Revised Manual for Forms L and M. Circle Pines, MN: American Guidance Service, 1981.
Ebert U and Loscher W. Strong olfactory stimulation reduces seizure susceptibility in amygdala-kindled rats. Neuroscience Letters, 2000, 287(3), 199–202.
Eccles R, Jawad MS and Morris S. The effects of oral administration of (-)-menthol on nasal resistance to airflow and nasal sensation of airflow in subjects suffering from nasal congestion associated with the common cold. Journal of Pharmacy and Pharmacology, 1990, 42, 652–4.
Eichenbaum H, Morton TH, Potter H and Corkin S. Selective olfactory deficits in case H.M. Brain, 1983, 106, 459–72.
Eichenbaum H, Morton TH, Potter H and Corkin S. Selective olfactory deficits in case H.M. Brain, 1983, 106, 459–72.
Elbaz A, Levecque C, Clavel J et al. CYP2D6 polymorphism pesticide exposure and Parkinson's disease. Annals of Neurology, 2004, 55(3), 430–4.
Elian M. Olfactory impairment in motor neuron disease: a pilot study. Journal of Neurology, Neurosurgery and Psychiatry, 1991, 54, 927–8.
Elsberg CA and Levy I. The sense of smell: I. A new and simple method of quantitative olfactometry. Bulletin of the Neurological Institute of New York, 1935, 4, 5–19.
Elsberg CA. The sense of smell XII. The localization of tumors of the frontal lobe of the brain by quantitative olfactory tests. Bulletin of the Neurological Institute of New York, 1935b, 4, 535–43.
Elsberg CA. XI. The value of quantitative olfactory tests for the localization of supratentorial tumors of the brain. A preliminary report. Bulletin of the Neurological Institute of New York, 1935a, 4, 511–22.
Engen T and Ross BM. Long-term memory of odors with and without verbal descriptions. Journal of Experimental Psychology, 1973, 100, 221–7.
Engen T and Ross BM. Long-term memory of odors with and without verbal descriptions. Journal of Experimental Psychology, 1973, 100, 221–7.
Engen T, Kuisma JE and Eimas PD. Short-term memory of odors. Journal of Experimental Psychology, 1973, 99, 222–5.
Eskenazi B, Cain WS, Novelly RA and Mattson R. Odor perception in temporal lobe epilepsy patients with and without temporal lobectomy. Neuropsychologia, 1986, 24(4), 553–62.
Evidente VG, Esteban RP, Hernandez JL et al. Smell testing is abnormal in ‘Lubag’ or X-linked dystonia-parkinsonism: a pilot study. Parkinsonism and Related Disorders, 2004, 10(7), 407–10.
Eyman RK, Kim PJ and Call T. Judgment error in category vs. magnitude scales. Perception and Motor Skills, 1975, 40, 415–23.
Fadool DA, Tucker K, Perkins R et al. Kv1.3 channel gene-targeted deletion produces “Super-Smeller Mice” with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron, 2004, 41(3), 389–404.
Fearnley JM and Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 1991, 114(Pt 5), 2283–301.
Fearnley JM, Stevens JM and Rudge P. Superficial siderosis of the central nervous system. Brain, 1995, 118(Pt 4), 1051–66.
Felton DL and Jozefowicz R. Netter's Atlas of Human Neuroscience. New York, NY: Elsevier, 2003.
Fend R, Kolk AH, Bessant C, Buijtels P, Klatser PR and Woodman AC. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. Journal of Clinical Microbiology, 2006, 44(6), 2039–45.
Fernandez-Ruiz J, Diaz R, Hall-Haro C et al. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport, 2003, 14, 1339–41.
Ferreira JJ, Guedes LC, Rosa MM et al. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal. Movement Disorders, 2007, 22(8), 1194–201.
Ferreyra-Moyano H and Barragan E. The olfactory system and Alzheimer's disease. International Journal of Neuroscience, 1989, 49(3–4), 157–97.
Ferreyra-Moyano H and Barragan E. The olfactory system and Alzheimer's disease. International Journal of Neuroscience, 1989, 49, 157–97.
Fiser Dj and Borotski L. Anosmia after administration of influenza vaccine. Medicinski Pregled, 1979, 32(9–10), 455–7.
Fish DR, Gloor P, Quesney FL and Olivier A. Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy. Pathophysiological implications. Brain, 1993, 116(Pt 2), 397–414.
Flanagan P and Eccles R. Spontaneous changes of unilateral nasal airflow in man. A re-examination of the nasal cycle. Acta Oto-Laryngologica, 1997, 117, 590–5.
Flexner S and Clark PF. A note on the mode of infection in epidemic poliomyelitis. Proceedings of the Society for Experimental Biology and Medicine, 1912, 10, 1–2.
Flexner S and Lewis PA. Experimental epidemic poliomyelitis in monkeys. Journal of Experimental Medicine, 1910, 12, 227–55.
Floriano WB, Vaidehi N, Goddard WA III, Singer MS and Shepherd GM. Molecular mechanisms underlying differential odor responses of a mouse olfactory receptor. Proceedings of the National Academy of Science of the United States of America, 2000, 97, 10 712–16.
Frijters JE. Three-stimulus procedures in olfactory psychophysics: an experimental comparison of Thurstone-Ura and three-alternative forced-choice models of signal detection theory. Perception and Psychophysics, 1980, 28, 390–7.
Frye RE and Doty RL. The influence of ultradian autonomic rhythms, as indexed by the nasal cycle, on unilateral olfactory thresholds. In: RL Doty and D Müller-Schwarze, eds. Chemical Signals in Vertebrates 6. New York, NY: Plenum Press, 1992, pp. 595–6.
Frye RE, Schwartz BS and Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA, 1990, 263, 1233–6.
Frye RE. Nasal airway dynamics and olfactory function. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 1995, pp. 471–91.
Fuller GN and Guiloff RJ. Migrainous olfactory hallucinations. Journal of Neurology, Neurosurgery, and Psychiatry, 1987, 50(12), 1688–90.
Galvin JE, Pollack J and Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology, 2006, 67(9), 1605–11.
Gauntlett-Gilbert J and Kuipers E. Phenomenology of visual hallucinations in psychiatric conditions. Journal of Nervous and Mental Disease, 2003, 191(3), 203–5.
Geisler MW and Murphy C. Event-related brain potentials to attended and ignored olfactory and trigeminal stimuli. International Journal of Psychophysiology, 2000, 37, 309–15.
Geisler MW, Morgan CD, Covington JW and Murphy C. Neuropsychological performance and cognitive olfactory event-related brain potentials in young and elderly adults. Journal of Clinical and Experimental Neuropsychology, 1999, 21, 108–26.
Geser F, Wenning GK, Poewe W and McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Movement Disorders, 2005, 20(Suppl. 12), S11–20.
Gesteland RC. Speculations on receptor cells as analyzers and filters. Experientia, 1986, 42, 287–91.
Gevins AS and Remond A. Methods of Analysis of Brain Electrical and Magnetic Signals. New York, NY: Elsevier, 1987.
Ghadami M, Morovvati S, Majidzadeh AK et al. Isolated congenital anosmia locus maps to 18p11.23-q12.2. Journal of Medical Genetics 2004, 41, 299–303.
Gheusi G, Cremer H, McLean H, Chazal G, Vincent JD and Lledo PM. Importance of newly generated neurons in the adult olfactory bulb for odor discrimination. Proceedings of the National Academy of Sciences of the United States of America, 2000, 97, 1823–8.
Gibberd FB, Feher MD, Sidey MC and Wierzbicki AS. Smell testing: an additional tool for identification of adult Refsum's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 2004, 75(9), 1334–6.
Gilad Y, Man O and Glusman G. A comparison of the human and chimpanzee olfactory receptor gene repertoires. Genome Research, 2005, 15, 224–30.
Gilbert AN and Rosenwasser AM. Biological rhythmicity of nasal airway patency: a re-examination of the ‘nasal cycle’. Acta Otolaryngologica, 1987, 104, 180–6.
Gilbert AN and Wysocki CJ. The Smell Survey results. National Geographic Magazine, 1987, 172, 514–25.
Gillner M, Brittebo EB, Brandt I, Söderkvist P, Appelgren L-E and Gustafsson J-A. Uptake and specific binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Research, 1987, 47, 4150–9.
Gillner M, Brittebo EB, Brandt I, Soderkvist Appelgren L-E and Gustafsson J-A. Uptake and specific binding of 2 3 7 8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Research, 1987, 47, 4150–9.
Gilman S and Winans S. Manter and Gatz's Essentials of Clinical Neuroanatomy and Neurophysiology (10th edition). Philadelphia, PA: FA Davis Publishers.
Glusman G, Yanai I, Rubin I and Lancet D. The complete human olfactory subgenome. Genome Research, 2001, 11, 685–702.
Goel N, Kim H and Lao RP. An olfactory stimulus modifies nighttime sleep in young men and women. Chronobiology International, 2005, 22, 889–904.
Goetz CG, Vogel C, Tanner CM and Stebbins GT. Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology, 1998, 51(3), 811–14.
Gold GH. Controversial issues in vertebrate olfactory transduction. Annual Review of Physiology, 1999, 61, 857–71.
Goldstein L, Stoltzfus NW and Gardocki JF. Changes in interhemispheric amplitude relationships in the EEG during sleep. Physiology and Behavior, 1972, 8, 811–15.
Gordon AS, Moran DT, Jafek BW, Eller PM and Strahan RC. The effect of chronic cocaine abuse on human olfaction. Archives of Otolaryngology, Head, and Neck Surgery, 1990, 116(12), 1415–18.
Gottfried JA and Dolan RJ. The nose smells what the eye sees: crossmodal visual facilitation of human olfactory perception. Neuron, 2003, 39(2), 375–86.
Gottfried JA and Zald DH. On the scent of human olfactory orbitofrontal cortex: meta-analysis and comparison to non-human primates. Brain Research and Brain Research Reviews, 2005, 50(2), 287–304.
Gottfried JA, Deichmann R, Winston JS and Dolan RJ. Functional heterogeneity in human olfactory cortex: an event-related functional magnetic resonance imaging study. Journal of Neuroscience, 2002, 22(24), 10 819–28.
Gottfried JA, Smith AP, Rugg MD and Dolan RJ. Remembrance of odors past: human olfactory cortex in cross-modal recognition memory. Neuron, 2004, 42(4), 687–95.
Gottfried JA, Winston JS and Dolan RJ. Dissociable codes of odor quality and odorant structure in human piriform cortex. Neuron, 2006, 49(3), 467–79.
Gottfried JA. Smell: central nervous processing. Advances in Oto-Rhino-Laryngology, 2006, 63, 44–69.
Gottofrey J and Tjalve H. Axonal transport of cadmium in the olfactory nerve of the pike. Pharmacology & Toxicology, 1991, 69, 242–52.
Graves AB, Bowen JD, Rajaram L et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology, 1999, 22(3), 1480–7.
Gray JM, Young AW, Barker WA, Curtis A and Gibson D. Impaired recognition of disgust in Huntington's disease gene carriers. Brain, 1997, 120(Pt 11), 2029–38.
Green BG, Dalton P, Cowart B, Shaffer G, Rankin K and Higgins J. Evaluating the “Labeled Magnitude Scale” for measuring sensations of taste and smell. Chemical Senses, 1996, 21, 323–34.
Gregson RA, Free ML and Abbott MW. Olfaction in Korsakoffs, alcoholics and normals. British Journal of Clinical Psychology, 1981, 20(Pt 1), 3–10.
Gresham LS, Molgaard CA and Smith RA. Induction of cytochrome P-450 enzymes via tobacco smoke: a potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases. Neuroepidemiology, 1993, 12(2), 114–16.
Guadagni DG, Buttery RG and Okano S. Odor thresholds of some organic compounds associated with food flavors. Journal of Food Science and Agriculture, 1963, 14, 761–5.
Gudziol H, Schubert M and Hummel T. Decreased trigeminal sensitivity in anosmia. Journal for Oto-Rhino-Laryngology and its Related Specialties, 2001, 63(2), 72–5.
Gulyas B, Keri S, O'Sullivan BT, Decety J and Roland PE. The putative pheromone androstadienone activates cortical fields in the human brain related to social cognition. Neurochemistry International, 2004, 44(8), 595–600.
Höglinger GU, Rizk P, Muriel MP et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nature Neuroscience, 2004, 7, 726–35.
Haberly LB and Price JL. Association and commissural fiber systems of the olfactory cortex of the rat. Journal of Comparative Neurology, 1978, 178, 711–40.
Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S and Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Movement Disorders, 2007, 22(6), 839–42.
Hagglund M, Berghard A, Strotmann J and Bohm S. Retinoic acid receptor-dependent survival of olfactory sensory neurons in postnasal and adult mice. Journal of Neuroscience, 2006, 26, 3281–91.
Hague C, Uberti MA, Chen Z et al. Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101, 13 672–6.
Haight JJ and Cole P. Reciprocating nasal airflow resistances. Acta Otolaryngologica, 1984, 97(1–2), 93–8.
Halasz N and Shepherd GM. Neurochemistry of the vertebrate olfactory bulb. Neuroscience, 1983, 10, 579–619.
Halgren E. Mental phenomena induced by stimulation in the limbic system. Human Neurobiology, 1982, 1(4), 251–60.
Hall HV and Pritchard DA. Detecting Malingering and Deception. Delray Beach, FL: St. Lucie Press, 1996.
Halliday G, Del Tredici K and Braak H. Critical appraisal of the Braak staging of brain pathology related to sporadic Parkinson's disease. Journal of Neural Transmission. Supplementum, 2006, 70, 99–103.
Hamilos DL. Chronic sinusitis. The Journal of Allergy and Clinical Immunology, 2000, 106, 213–27.
Hamilton JM, Murphy C and Paulsen JS. Odor detection learning and memory in Huntington's disease. Journal of the International Neuropsychological Society, 1999, 5, 609–15.
Hardy J. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: ‘permissive templating’ as a general mechanism underlying neurodegeneration. Biochemical Society Transactions, 2005, 33(Pt 4), 578–81.
Harrison PJ. Neurodegeneration and the nose. Clinical Otolaryngology and Allied Sciences, 1990, 15(4), 289–91.
Hawkes CH and Deeb J. Predicting Parkinson's disease, worthwhile but we are not there yet. Practical Neurology, 2006, 6, 272–7.
Hawkes CH and Shephard BC. Olfactory evoked responses and identification tests in neurological disease. Annals of the New York Academy of Sciences, 1998, 855, 608–15.
Hawkes CH and Shephard BC. Olfactory impairment in Parkinson's disease: evidence of dysfunction measured by olfactory-evoked potentials and smell identification tests. Annals of Neurology, 1992, 32, 248 (abstract).
Hawkes CH and Shephard BC. Selective anosmia in Parkinson's disease? Lancet, 1993, 341 (8842), 435–6.
Hawkes CH and Shephard BC. Selective anosmia in Parkinson's disease? Lancet, 1993, 341(8842), 435–6.
Hawkes CH, Del Tredici K and Braak N. Parkinson's disease: a dual-hit hypothesis. Neuropathology and Applied Neurobiology, 2007, 33(6), 599–614.
Hawkes CH, Fogo A and Shah M. Smell identification declines from age 36 years and mainly affects pleasant odors. Movement Disorders, 2005, 20(Suppl. 10), 160 (abstract).
Hawkes CH, Shah M and Fogo A. Smell identification declines from age 36 years and mainly affects pleasant odors. Neurology, 2005, Abs. P01.147. Number 6, Supplement 1.
Hawkes CH, Shephard BC and Daniel SE. Olfactory dysfunction in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 1997, 62, 436–46.
Hawkes CH, Shephard BC and Daniel SE. Olfactory dysfunction in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 1997, 62, 436–46.
Hawkes CH, Shephard BC and Kobal G. Assessment of olfaction in multiple sclerosis: evidence of dysfunction by olfactory evoked response and identification tests. Journal of Neurology, Neurosurgery, and Psychiatry, 1997, 63(2), 145–51.
Hawkes CH, Shephard BC, Geddes JF, Body GD and Martin JE. Olfactory disorder in motor neuron disease. Experimental Neurology, 1998, 50, 248–53.
Hawkes CH, Shepherd BC and Daniel SE. Is Parkinson's disease a primary olfactory disorder? Quarterly Journal of Medicine, 1999, 92, 473–80.
Hawkes CH. Olfaction in neurodegenerative disorder. Movement Disorders, 2003, 18, 364–72.
Hawkes CH. Parkinson's disease and aging: the same or a different process? Journal of Neurology Neurosurgery and Psychiatry, 2007, 78, 206 (abstract).
Hayden GR. Olfactory diagnosis in medicine. Postgraduate Medicine, 1980, 67, 110–16.
Heilmann S, Strehle G, Rosenheim K, Damm M and Hummel T. Clinical assessment of retronasal olfactory function. Archives of Otolaryngology – Head and Neck Surgery, 2002, 128, 414–18.
Heinrichs L. Linking olfaction with nausea and vomiting of pregnancy recurrent abortion hyperemesis gravidarum and migraine headache. American Journal of Obstetrics and Gynecology, 2002, 186(5 Suppl.), S215–19.
Helson H. Adaptation-Level Theory: An Experimental and Systematic Approach to Behavior. New York, NY: Harper & Row, 1964.
Hemdal P, Corwin J and Oster H. Olfactory identification deficits in Down's syndrome and idiopathic mental retardation. Neuropsychologia, 1993, 31, 977–84.
Henkin RI, Schechter PJ, Friedewald WT et al. A double-blind study of the effects of zinc sulfate on taste and smell dysfunction. American Journal of Medical Science, 1976, 272, 167–74.
Henkin RI, Talal N, Larson AL and Mattern CF. Abnormalities of taste and smell in Sjogren's syndrome. Annals of Internal Medicine, 1972, 76(3), 375–83.
Henkin RI. Abnormalities of taste and olfaction in patients with chromatin negative gonadal dysgenesis. Journal of Clinical Endocrinology and Metabolism, 1967, 27(10), 1436–40.
Henley DV, Lipson N, Korach KS and Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. New England Journal of Medicine, 2007, 356(5), 479–85.
Hensiek AE, Bhatia K and Hawkes CH. Olfactory function in drug induced parkinsonism. Journal of Neurology, 2000, 247(Suppl. 3), P303, III/82.
Hentschel K, Baba Y, Williams LN et al. Olfaction in familial Parkinsonism (FP). Movement Disorders, 2005, 20(Suppl. 10), p. 175.
Herz RS. A naturalistic analysis of autobiographical memories triggered by olfactory visual and auditory stimuli. Chemical Senses, 2004, 29(3), 217–24.
Herz RS. Are odors the best cues to memory? A cross-modal comparison of associative memory stimuli. Annals of the New York Academy of Sciences, 1998, 855, 670–4.
Hext PM and Lock EA. The accumulation and metabolism of 3-trifluoromethylpyridine by rat olfactory and hepatic tissues. Toxicology, 1992, 72, 61–75.
Hext PM and Lock EA. The accumulation and metabolism of 3-trifluoromethylpyridine by rat olfactory and hepatic tissues. Toxicology, 1992, 72, 61–75.
Hinds JW and McNelly NA. Aging in the rat olfactory system: correlation of changes in the olfactory epithelium and olfactory bulb. Journal of Comparative Neurology, 1981, 203, 441–53.
Hinds JW and McNelly NA. Aging of the rat olfactory bulb: growth and atrophy of constituent layers and changes in size and number of mitral cells. Journal of Comparative Neurology, 1977, 72, 345–67.
Hinds JW, Hinds PL and McNelly NA. An autoradiographic study of the mouse olfactory epithelium: evidence for long-lived receptors. Anatomical Record, 1984, 210, 375–83.
Hirotsune S, Yoshida N, Chen A et al. An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. Nature, 2003, 423, 91–6.
Hirsch AR. Olfaction in migraineurs. Headache, 1992, 32(5), 233–6.
Ho WK, Kwong DL, Wei WI and Sham JS. Change in olfaction after radiotherapy for nasopharyngeal cancer – a prospective study. American Journal of Otolaryngology, 2002, 23(4), 209–14.
Hockaday TDR. Hypogonadism and life-long anosmia. Postgraduate Medical Journal, 1966, 42, 572–4.
Hockstein NG, Thaler ER, Lin Y, Lee DD and Hanson CW. Correlation of pneumonia score with electronic nose signature: a prospective study. Annals of Otology, Rhinology and Laryngology, 2005, 114(7), 504–8.
Hooper MW and Vogel FS. The limbic system in Alzheimer's disease. American Journal of Pathology, 1976, 95, 1–13.
Hornung DE. Nasal anatomy and the sense of smell. Advances in Oto-RhinoLaryngology, 2006, 63, 1–22.
Huard JM, Youngentob SL, Goldstein BL, Luskin MB and Schwob JE. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. Journal of Comparative Neurology, 1998, 400, 469–86.
Hudry J, Ryvlin P, Royet JP and Mauguiere F. Odorants elicit evoked potentials in the human amygdala. Cerebral Cortex, 2001, 11(7), 619–27.
Hudson R, Arriola A, Martinez-Gomez M and Distel H. Effect of air pollution on olfactory function in residents of Mexico City. Chemical Senses, 2006, 31, 79–85.
Huisman E, Uylings HB and Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Movement Disorders, 2004, 19(6), 687–92.
Hummel T, Heilmann S and Huttenbriuk KB. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope, 2002, 112, 2076–80.
Hummel T, Kobal G, Gudziol H and Mackay-Sim A. Normative data for the “Sniffin' Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3000 subjects. European Archives of Otorhinolaryngology, 2007, 264(3), 237–43.
Hummel T, Mojet J and Kobal G. Electro-olfactograms are present when odorous stimuli have not been perceived. Neuroscience Letters, 2006, 397(3), 224–8.
Hummel T, Pauli E, Schuler P, Kettenmann B, Stefan H and Kobal G. Chemosensory event-related potentials in patients with temporal lobe epilepsy. Epilepsia, 1995, 36(1), 79–85.
Hummel T, Roscher S, Jaumann MP and Kobal G. Intranasal chemoreception in patients with multiple chemical sensitivities: a double-blind investigation. Regulatory Toxicology and Pharmacology, 1996, 24(1 Pt 2), S79–86.
Hummel T, Sekinger B, Wolf SR, Pauli E and Kobal G. “Sniffin' sticks:” olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chemical Senses, 1997, 22, 39–52.
Ibrahim A, Li Y, Li D, Raisman G and El Masry WS. Olfactory ensheathing cells: ripples of an incoming tide? Lancet Neurology, 2006, 5(5), 453–7.
Iranzo A, Molinuevo JL, Santamaria J et al. Rapid-eye-movement sleep behavior disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurology, 2006, 5(7), 572–7.
Iscan M, Reuhl K, Weiss B and Maines MD. Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Biochemical and Biophysical Research Communications, 1990, 169(3), 858–63.
Itzhaki R and Itzhaki R. Herpes simplex virus type 1, apolipoprotein E and Alzheimer's disease. Herpes, 2004, 11(Suppl. 2), 77A–82A.
Jackman AH and Doty RL. Utility of a 3-item smell identification test in detecting olfactory dysfunction. Laryngoscope, 2005, 115, 2209–12.
Jackman AH and Doty RL. Utility of a three-item smell identification test in detecting olfactory dysfunction. Laryngoscope, 2005, 115(12), 2209–12.
Jacob TJ, Wang L, Jaffer S and McPhee S. Changes in the odor quality of androstadienone during exposure-induced sensitization. Chemical Senses, 2006, 31(1), 3–8.
Jafek BW, Eller PM, Esses BA and Moran DT. Post-traumatic anosmia. Ultrastructural correlates. Archives of Neurology 1989, 46(3), 300–4.
Jafek BW, Eller PM, Esses BA and Moran DT. Post-traumatic anosmia. Ultrastructural correlates. Archives of Neurology, 1989, 46(3), 300–4.
Jellinger K, Braak H, Braak E and Fischer P. Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Annals of the New York Academy of Sciences, 1991, 640, 203–9.
Jones BP, Butters N, Moskowitz HR and Montgomery K. Olfactory and gustatory capacities of alcoholic Korsakoff patients. Neuropsychologia, 1978, 16, 323–37.
Jones BP, Moskowitz HR, Butters N and Glosser G. Psychophysical scaling of olfactory, visual, and auditory stimuli by alchoholic Korsakoff patients. Neuropsychologia, 1975b, 13, 387–93.
Jones BP, Moskowitz RH and Butters N. Olfactory discrimination in alcoholic Korsakoff patients. Neuropsychologia, 1975a, 13(2), 173–9.
Jones N. The nose and paranasal sinuses: physiology and anatomy. Advanced Drug Delivery Reviews, 2001, 51, 5–19.
Jones-Gotman M and Zatorre RJ. Olfactory identification deficits in patients with focal cerebral excision. Neuropsychologia, 1988, 26(3), 387–400.
Joyner RE. Olfactory acuity in an industrial population. Journal of Occupational Medicine, 1963, 5, 37–42.
Kalaitzakis ME, Graeber MB, Gentleman SM and Pearce RKB. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathology and Applied Neurobiology, 2008, 34(3), 284–95.
Kalmey JK, Thewissen JG and Dluzen DE. Age-related size reduction of foramina in the cribriform plate. Anatomical Record, 1998, 251(3), 326–9.
Kalmey JK, Thewissen JG and Dluzen DE. Age-related size reduction of foramina in the cribriform plate. Anatomical Record, 1998, 251, 326–9.
Kareken DA, Doty RL, Moberg P J et al. Olfactory-evoked regional cerebral blood flow in Alzheimer's disease Neuropsychology, 2001, 15(1), 18–29.
Kareken DA, Doty RL, Moberg PJ et al. Olfactory-evoked regional cerebral blood flow in Alzheimer's disease. Neuropsychology, 2001, 15(1), 18–29.
Karlson P and Lüscher M. “Pheromones:” a new term for a class of biologically active substances. Nature, 1959, 183, 55–6.
Katzenschlager R, Zijlmans J, Evans A, Watt H and Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 2004, 75(12), 1749–52.
Katzman R. Alzheimer's disease. New England Journal of Medicine, 1986, 314, 964–73.
Kaufmann H, Nahm K, Purohit D and Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology, 2004, 63(6), 1093–5.
Kaupp UB and Seifert R. Cyclic nucleotide-gated ion channels. Physiological Reviews, 2002, 82(3), 769–824.
Kelman L. Osmophobia and taste abnormality in migraineurs: a tertiary care study. Headache, 2004b, 44(10), 1019–23.
Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache, 2004a, 44(9), 865–72.
Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope, 2000, 110(7), 1071–7.
Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope, 2000, 110, 1071–7.
Kesslak JP, Cotman CW, Chui HC et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiology of Aging, 1988, 9, 399–403.
Keyhani K, Scherer PW and Mozell MM. Numerical simulation of airflow in the human nasal cavity. Journal of Biomechanical Engineering, 1995, 117(4), 429–41.
Khan NL, Jain S, Lynch JM et al. Mutations in the gene LRRK2 encoding dardarin (PARK 8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain, 2005, 128(Pt 12), 2786–96.
Khan NL, Katzenschlager R, Watt H et al. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology, 2004, 62(7), 1224–6.
Killgore WDS and McBride SH. Odor identification accuracy declines following 24 h of sleep deprivation. Journal of Sleep Research, 2006, 15(2), 111–16.
Kishikawa M, Iseki M, Nishimura M, Sekine I and Fujii H. A histopathological study on senile changes in the human olfactory bulb. Acta Pathologica Japonica, 1990, 40, 255–60.
Kishikawa M, Iseki M, Sakae M, Kawaguchi S and Fujii H. Early diagnosis of Alzheimer's? Nature, 1994, 369(6479), 365–6.
Klein R, Pilon D, Prosser S and Shannahoff-Khalsa D. Nasal airflow asymmetries and human performance. Biological Psychology, 1986, 23, 127–37.
Klimek L. Sense of smell in allergic rhinitis. Pneumologie, 1998, 52, 196–202.
Kobal G and Hummel C. Cerebral chemosensory evoked potentials elicited by chemical stimulation of the human olfactory and respiratory nasal mucosa. Electroencephalography and Clinical Neurophysiology, 1988, 71, 241–50.
Kobal G and Plattig KH. Methodische Anmerkungen zur Gewinnung olfaktorischer EEG-Antworten des wachen Menschen (objektive Olfaktometrie). Zeitschrift fur Elektroenzephalographie Elektromyographie und Verwandte Gebiete, 1978, 9, 135–45.
Kobal G and Plattig KH. Objective olfactometry: methodological annotations for recording olfactory EEG-responses from the awake human. Elektroenzephalogr Elektromyogr Verwandte Geb, 1978, 9, 135–45.
Kobal G, Hummel T and Van Toller S. Differences in human chemosensory evoked potentials to olfactory and somatosensory chemical stimuli presented to left and right nostrils. Chemical Senses 1992, 17, 233–44.
Kobal G, Hummel T, Sekinger B, Barz S, Roscher S and Wolf S. “Sniffin' sticks”: screening of olfactory performance. Rhinology, 1996, 34, 222–6.
Kobal G, Van Toller S and Hummel T. Is there directional smelling? Experientia, 1989, 45, 130–2.
Kobal G. Electrophysiological measurement of olfactory function. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 229–49.
Kobal G. Elektrophysiologische Untersuchungen des menschlichen Geruchssinns. Stuttgart, Germany: Thieme, 1981.
Kohler CG Moberg PJ Gur RE O'Connor MJ Sperling MR and Doty RL. Olfactory dysfunction in schizophrenia and temporal lobe epilepsy. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 2001, 14(2), 83–8.
Kopala L and Clark C. Implications of olfactory agnosia for understanding sex differences in schizophrenia. Schizophrenia Bulletin, 1990, 16(2), 255–61.
Kopala L, Clark C and Hurwitz TA. Sex differences in olfactory function in schizophrenia. American Journal of Psychiatry, 1989, 146(10), 1320–2.
Kopala LC, Good KP, Morrison K, Bassett AS, Alda M and Honer WG. Impaired olfactory identification in relatives of patients with familial schizophrenia. American Journal of Psychiatry, 2001, 158(8), 1286–90.
Kovacs T, Cairns NJ and Lantos PL. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport, 2001, 12 (12), 285–8.
Kovacs T, Papp MI, Cairns NJ, Khan MN and Lantos PL. Olfactory bulb in multiple system atrophy. Movement Disorders, 2003, 18(8), 938–42.
Kramer G. Diagnosis of neurologic disorders after whiplash injuries of the cervical spine. Deutsche Medizinische Wochenschrift, 1983, 108(15), 586–8.
Kramer G. Diagnosis of neurologic disorders after whiplash injuries of the cervical spine. Deutsche Medizinische Wochenschrrift, 1983, 108(15), 586–8.
Kratskin IL and Belluzzi O. Anatomy and neurochemistry of the olfactory bulb. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 139–64.
Krmpotic-Nemanic J. Presbycusis, presbystasis and presbyosmia as consequences of the analogous biological process. Acta Otolaryngologica, 1969, 67, 217–23.
Kulaga HM, Leitch CC, Eichers ER et al. Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nature Genetics, 2004, 36, 994–8.
Laing DG. Natural sniffing gives optimum odor perception for humans. Perception, 1983, 12, 99–117.
Lane AP, Zweiman B, Lanza DC et al. Acoustic rhinometry in the study of the acute nasal allergic response. Annals of Otology, Rhinology and Laryngology, 1996, 105, 811–18.
Lane RP, Smutzer GS and Doty RL. Sense of smell. In: RA Meyers, ed. Encyclopeda of Molecular Cell Biology and Molecular Medicine. Weinheim: Wiley–VCH Verlag GmbH & Co., KGaA, 2005, pp. 637–705.
Larsson M, Lovden M and Nilsson LG. Sex differences in recollective experience for olfactory and verbal information. Acta Psychologica, 2003, 112, 89–103.
Lawless HT and Malone GT. A comparison of rating scales: sensitivity, replicates and relative measurement. Journal of Sensory Studies, 1986b, 1, 155–74.
Lawless HT and Malone GT. The discrimination efficiency of common scaling methods. Journal of Sensory Studies, 1986a, 1, 85–98.
Lee HY, Kim HU, Kim SS et al. Surgical anatomy of the sphenopalatine artery in lateral nasal wall. Laryngoscope, 2002, 112, 1813–18.
Lee SJ, Yoo HJ, Park SW and Choi MG. A case of cystic lymphocytic hypophysitis with cacosmia and hypopituitarism. Endocrine Journal, 2004, 51(3), 375–80.
Lehrner J, Baumgartner C, Serles W et al. Olfactory prodromal symptoms and unilateral olfactory dysfunction are associated in patients with right mesial temporal lobe epilepsy. Epilepsia, 1997, 38(9), 1042–4.
Leopold DA, Hummel T, Schwob JE, Hong SC, Knecht M and Kobal G. Anterior distribution of human olfactory epithelium. Laryngoscope, 2000, 110(3 Pt 1), 417–21.
Leopold DA. The relationship between nasal anatomy and human olfaction. Laryngoscope, 1988, 98, 1232–8.
Leypold BG, Yu CR, Leinders-Zufall T, Kim MM, Zufall F and Axel R. Altered sexual and social behaviors in trp2 mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99(9), 6376–81.
Li AA, Mink PJ, McIntosh LJ, Teta MJ and Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease. Journal of Occupational and Environmental Medicine, 2005, 47(10), 1059–87.
Li W, Luxenberg E, Parrish T and Gottfried JA. Learning to smell the roses: experience-dependent neural plasticity in human piriform and orbitofrontal cortices. Neuron, 2006, 52(6), 1097–108.
Liberini P, Parola S, Spano PF and Antonini L. Olfaction in Parkinson's disease: methods of assessment and clinical relevance. Journal of Neurology, 2000, 247, 88–96.
Liberles SD and Buck LB. A second class of chemosensory receptors in the olfactory epithelium. Nature, 2006, 442(7103), 645–50.
Lill K, Reden J, Muller A, Zahnert T and Hummel T. Olfactory function in patients with post-infectious and post-traumatic smell disorders before and after treatment with vitamin A: a double-blind, placebo-controlled, randomized clinical trial. Chemical Senses, 2006, 31(5), Abstract A33.
Liman ER, Corey DP and Dulac C. TRP2: a candidate transduction channel for mammalian pheromone sensory signaling. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96, 5791–6.
Linschoten MR, Harvey LO Jr, Eller PM and Jafek BW. Fast and accurate measurement of taste and smell thresholds using a maximum-likelihood adaptive staircase procedure. Perception and Psychophysics, 2001, 63, 1330–47.
Liou HH, Tsai MC, Chen CJ et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology, 1997, 48(6), 1583–8.
Lois C, Garcia-Verdugo JM and Varez-Buylla A. Chain migration of neuronal precursors. Science, 1996, 271, 978–81.
London B, Nabet B, Fisher AR, White B, Sammel MD and Doty RL Predictors of prognosis in patients with olfactory disturbance. Annals of Neurology, 2008, 63(2), 159–66.
London B, Nabet B, Fisher AR, White B, Sammel MD and Doty RL. Predictors of prognosis in patients with olfactory disturbance. Annals of Neurology, 2008, 63, 159–66.
London B, Nabet B, Fisher AR, White B, Sammel MD and Doty RL. Predictors of prognosis in patients with olfactory disturbances. Annals of Neurology, 2008, 63, 159–66.
Lorig TS, Elmes DG, Zald DH and Pardo JV. A computer-controlled olfactometer for fMRI and electrophysiological studies of olfaction. Behavior Research Methods, Instruments, and Computers, 1999, 31, 370–5.
Louis ED and Jurewicz EC. Olfaction in essential tremor patients with and without isolated rest tremor. Movement Disorders, 2003, 18(11), 1387–9.
Louis ED, Bromley SM, Jurewicz EC and Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology, 2002, 59(10), 1631–3.
Louis ED, Vonsattel JP, Honig LS, Ross GW, Lyons KE and Pahwa R. Neuropathologic findings in essential tremor. Neurology, 2006, 66(11), 1756–9.
Lovell MA. Jafek BW, Moran DT and Rowley JC. Biopsy of human olfactory mucosa: an instrument and a technique. Archives of Otolaryngology, 1982, 108(4), 247–9.
Lumsden CE. The neuropathology of multiple sclerosis. In: PJ Vinken and GW Bruyn, eds, Handbook of Clinical Neurology. New York, NY: Elsevier, 1983, p. 217.
Lundstrom JN, Hummel T and Olsson MJ. Individual differences in sensitivity to the odor of 4 16-androstadien-3-one. Chemical Senses, 2003, 28(7), 643–50.
Lundstrom JN, Seven S, Olsson MJ, Schaal B and Hummel T. Olfactory event-related potentials reflect individual differences in odor valence perception. Chemical Senses, 2006, 31(8), 705–11.
Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L and Lambon Ralph MA. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia, 2007, 45(8), 1823–31.
Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L and Lambon Ralph MA. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia, 2007, 45(8), 1823–31.
Lygonis CS. Familiar absence of olfaction. Hereditas, 1969, 61(3), 413–6.
Mace JW, Goodman SI, Centerwall WR and Chinnock RF. The child with an unusual odor. Clinical Pediatrics, 1976, 15, 57–62.
Mackay-Sim A. Neurogenesis in the adult olfactory neuroepithelium. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 93–114.
Mahajan SK, Prasad AS, Briggs WA et al. Improvement in uremic hypogeusia by zinc: a double-blind study. American Journal of Clinical Nutrition, 1980, 33, 1517–21.
Mainland J and Sobel N. The sniff is part of the olfactory percept. Chemical Senses, 2006, 31(2), 181–96.
Mainland RC. Absence of olfactory sensation. Journal of Heredity, 1945, 36, 143–4.
Mair RG, Doty RL, Kelly KM et al. Multimodal sensory discrimination deficits in Korsakoff's psychosis. Neuropsychologia, 1986, 24(6), 831–9.
Mallet AI, Holland KT, Rennie PJ, Watkins WJ and Gower DB. Applications of gas chromatography–mass spectrometry in the study of androgen and odorous 16-androstene metabolism by human axillary bacteria. Journal of Chromatography, 1991, 562(1–2), 647–58.
Mann DM. Alzheimer's disease and Down's syndrome. Histopathology, 1988, 13, 125–37.
Mann DM. The pathogenesis and progression of the pathological changes of Alzheimer's disease. Annals of Medicine, 1989, 21(2), 133–6.
Markopoulou K, Larsen KW and Wszolek EK et al. Olfactory dysfunction in familial parkinsonism. Neurology, 1997, 49, 1262–7.
Marks LE. Magnitude estimation and sensory matching. Perception and Psychophysics, 1988, 43, 511–25.
Marks LE. Sensory Processes. New York, NY: Academic Press, 1974.
Marras C, Goldman S and Smith A et al. Smell identification ability in twin pairs discordant for Parkinson's disease. Movement Disorders, 2005, 20(6), 687–93.
Martzke JE, Swan CS and Varney NR. Posttraumatic anosmia and orbital frontal damage: neuropsychological and neuropsychiatric correlates. Neuropsychology, 1991, 5, 213–25.
Maruniak JA, Mason JR and Kostelc JG. Conditioned aversions to an intravascular odorant. Physiology and Behavior, 1983, 30(4): 617–20.
Masucci MG. Epstein–Barr virus oncogenesis and the ubiquitin-proteasome system. Oncogene, 2004, 23, 2107–15.
McCaffrey TV. Rhinomanometry and vasoactive drugs affecting nasal patency. In: TV Getchell, RL Doty, LM Bartoshuk and JB. Snow Jr, eds. Smell and Taste in Health and Disease. New York, NY: Raven Press, 1991, pp. 493–502.
McClintock MK. Menstrual synchrony and suppression. Nature, 1971, 229, 244–5.
McDonald WI. The mystery of the origin of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 1986, 49, 113–23.
McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Journal of Alzheimer's Disease, 2006, 9(Suppl. 3), 417–23.
McKeown DA, Doty RL, Perl DP, Frye RE, Simms I and Mester A. Olfactory function in young adolescents with Down's syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 1996, 61, 412–14.
McShane RH, Nagy Z, Esiri MM et al. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. Journal of Neurology, Neurosurgery and Psychiatry, 2001, 70, 739–43.
Meisami E, Mikhail L, Baim D and Bhatnagar KP. Human olfactory bulb: aging of glomeruli and mitral cells and a search for the accessory olfactory bulb. Annals of the New York Academy of Sciences, 1998, 855, 708–15.
Menco BPM and Morrison EE. Morphology of the mammalian olfactory epithelium: form, fine structure, function, and pathology. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 17–49.
Mendez MF and Ghajarnia M. Agnosia for familiar faces and odors in a patient with right temporal lobe dysfunction. Neurology, 2001, 57(3), 519–21.
Mesholam RI, Moberg PJ, Mahr RN and Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Archives of Neurology, 1998, 55, 84–90.
Mirza N, Kroger H and Doty RL. Influence of age on the ‘nasal cycle’. Laryngoscope, 1997, 107, 62–6.
Mishra A, Saito K, Barbash SE, Mishra N and Doty RL. Olfactory dysfunction in leprosy. Laryngoscope, 2006, 116, 413–16.
Mitchell IJ, Heims H, Neville EA and Rickards H. Huntington's disease patients show impaired perception of disgust in the gustatory and olfactory modalities. Journal of Neuropsychiatry and Clinical Neuroscience, 2005, 17(1), 119–21.
Miwa T, Watanabe A, Mitsumoto Y, Furukawa M, Fukushima N and Moriizumi T. Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1 2 3 6-tetrahydropyridine. Acta Otolaryngologica, 2004, 553(Suppl.), 80–4.
Moberg PJ and Doty RL. Olfactory function in Huntington's disease patients and at-risk offspring. International Journal of Neuroscience, 1997, 89, 133–9.
Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI and Doty RL Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology, 1999, 21(3), 325–40.
Moberg PJ, Arnold SE, Doty RL et al. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. Journal of Clinical and Experimental Neuropsychology, 2006, 28, 1444–61.
Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME and Folstein SE. Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 1987, 9, 650–64.
Mombaerts P, Wang F, Dulac C et al. Visualizing an olfactory sensory map. Cell, 1996, 87, 675–86.
Mombaerts P. How smell develops. Nature and Neuroscience, 2001, 4(Suppl.), 119–28.
Montgomery EB Jr, Baker KB, Lyons K and Koller WC. Abnormal performance on the PD test battery by asymptomatic first-degree relatives. Neurology, 1999, 52, 757–62.
Montgomery EB Jr, Lyons K and Koller WC. Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery. Movement Disorders, 2000, 15(3), 474–8.
Moran DT, Rowley JC III, Jafek BW and Lovell MA. The fine structure of the olfactory mucosa in man. Journal of Neurocytology, 1982, 11, 721–46.
Morgan CD and Murphy C. Olfactory event-related potential in Alzheimer's disease. Journal of the International Neuropsychological Society, 2002, 8, 753–63.
Moskowitz HR. Magnitude estimation: notes on what, how, when, and why to use it. Journal of Food Quality, 1977, 3, 195–227.
Mourad I, Lejoyeux M and Ades J. Prospective evaluation of antidepressant discontinuation Encephale, 1998, 24(3), 215–22.
Mozell MM, Kent PF and Murphy SJ. The effect of flow rate upon the magnitude of the olfactory response differs for different odors. Chemical Senses, 1991, 16, 631–49.
Mueller CA, Grassinger E, Naka A, Temmel AF, Hummel T and Kobal G. A self-administered odor identification test procedure using the “Sniffin' Sticks”. Chemical Senses, 2006, 31, 595–8.
Muller A, Mungersdorf M, Reichmann H, Strehle G and Hummel T. Olfactory function in Parkinsonian syndromes. Journal of Clinical Neuroscience, 2002, 9(5), 521–4.
Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M and Braak H. Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. Journal of Neuropathology and Experimental Neurology, 2005, 64(7), 623–8.
Murphy C and Jinich S. Olfactory dysfunction in Down's syndrome. Neurobiology of Aging, 1996, 17, 631–7.
Murphy C, Schubert CR. Cruickshanks KJ. Klein BE. Klein R and Nondahl DM. Prevalence of olfactory impairment in older adults. Journal of the American Medical Association, 2002, 288(18), 2307–12.
Murphy C, Shubert CR, Cruickshanks KJ, Klein BE, and Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA, 2002, 288, 2307–12.
Murphy M, Doty RL and Duncan HJ. Clinical disorders of olfaction. In: RL Doty, ed., Handbook of Olfaction and Gustation (2nd edition). New York, NY: Marcel Dekker, 2003, Chapter 22, pp. 461–78.
Mygind N and Pedersen M. Nose- sinus- and ear-symptoms in 27 patients with primary ciliary dyskinesia. European Journal of Respiratory Diseases, 1983, 127(Suppl.), 96–101.
Nakashima T, Kidera K, Miyazaki J, Kuratomi Y and Inokuchi A. Smell intensity monitoring using metal oxide semiconductor odor sensors during intravenous olfactoin test. Chemical Senses, 2006, 31, 43–7.
Nakashima T, Kimmelman CP and Snow JB Jr. Structure of human fetal and adult olfactory neuroepithelium. Archives of Otolaryngology, 1984, 110, 641–6.
Nee LE and Lippa CF. Inherited Alzheimer's disease PS-1 olfactory function: a 10-year follow-up study. American Journal of Alzheimer's Disease and Other Dementias, 2001, 16(2), 83–4.
Nee LE, Scott J and Polinsky RJ. Olfactory dysfunction in the Shy–Drager syndrome. Clinical Autonomic Research, 1993, 3(4), 281–2.
Neely G, Ljunggren G, Sylven C and Borg G. Comparison between the Visual Analogue Scale (VAS) and the Category Ratio Scale (CR-10) for the evaluation of leg exertion. International Journal of Sports Medicine, 1992, 13, 133–6.
Newman R and Winans SS. An experimental study of the ventral striatum of the golden hamster. II Neuronal connections of the olfactory tubercle. Journal of Comparative Neurology, 1980, 191, 193–212.
Nijjar RK and Murphy C. Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiology of Aging, 2002, 23(1), 65–73.
Nordin S, Almkvist O, Berglund B and Wahlund LO. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Archives of Neurology, 1997, 54(8), 993–8.
Nordin S, Almkvist O, Berglund B and Wahlund LO. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Archives of Neurology, 1997, 54(8), 993–8.
Nordin S, Broman DA, Olofsson JK and Wulff M. A longitudinal descriptive study of self-reported abnormal smell and taste perception in pregnant women. Chemical Senses, 2004, 29, 391–402.
Nordin S, Lotsch J, Kobal G and Murphy C. Effects of nasal-airway volume and body temperature on intranasal chemosensitivity. Physiology and Behavior, 1998, 63, 463–6.
Nordin S, Monsch AU and Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. Journal of Gerontology, 1995, 50, 187–92.
Nordin S, Monsch AU and Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. Journal of Gerontology. Series B, Psychological Sciences and Social Sciences, 1995a, 50(4), P187–92.
Nordin S, Paulsen JS and Murphy C. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. Journal of the International Neuropsychological Society, 1995b, 1, 281–90.
Oberg C, Larsson M and Backman L. Differential sex effects in olfactory functioning: the role of verbal processing. Journal of the International Neuropsychological Society, 2002, 8, 691–8.
Ogawa T and Rutka J. Olfactory dysfunction in head injured workers. Acta Otolaryngologica, 1999; 540(Suppl.), 50–7.
Ohm TG and Braak H. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathologica, 1987, 73, 365–9.
Oka Y, Nakamura A, Watanabe H and Touhara K. An odorant derivative as an antagonist for an olfactory receptor. Chemical Senses, 2004, 29, 815–22.
Okamoto K, Hirai S, Shoji M and Takatama M. Senile changes in the human olfactory bulbs. In: T Nagatsu, ed. Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases. New York, NY: Plenum Press, 1990, pp. 349–52.
Olichney JM, Murphy C, Hofstetter CR et al. Anosmia is very common in the Lewy body variant of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 2005, 76(10), 1342–7.
Oliver C, Holland AJ. Down's syndrome and Alzheimer's disease: a review. Psychological Medicine, 1986, 16, 307–22.
Oyanagi K. The nature of the parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam and magnesium deficiency. Parkinsonism and Related Disorders, 2005, 11(Suppl. 1), S17–23.
Pager J, Giachetti I, Holley A and LeMagnen J. A selective control of olfactory bulb electrical activity in relation to food deprivation and satiety in rats. Physiological Behavior, 1972, 9, 573–9.
Pain S. Stench warfare. New Scientist, 2001, 2298, 43–5.
Papaioannou N, Tooten PC, van Ederen AM et al. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid, 2001, 8(1), 11–21.
Parkkinen L, Kauppinen T, Pirttila T, Autere JM and Alafuzoff I. α-Synuclein pathology does not predict extrapyramidal symptoms or dementia. Annals of Neurology, 2005, 57, 82–91.
Patel SJ, Bollhoefer AD and Doty RL. Influences of ethanol ingestion on olfactory function in humans. Psychopharmacology, 2004, 171, 429–34.
Patterson PM and Lauder BA. The incidence and probable inheritance of “smell blindness” to normal butyl mercaptan. Journal of Heredity, 1948, 39, 295–7.
Paulsen JS, Langbehn DR, Stout JC et al. Detection of Huntingdon's disease decades before diagnosis: the predict-HD study. Journal of Neurology Neurosurgery and Psychiatry, 2008, 79, 874–80.
Pause BM, Sojka B and Ferstl R. Central processing of odor concentration is a temporal phenomenon as revealed by chemosensory event-related potentials (CSERP). Chemical Senses, 1997, 22, 9–26.
Pavese N, Gerhard A, Tai YF et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology, 2006, 66(11), 1638–43.
Pavlou AK, Magan N, Sharp D, Brown J, Barr H and Turner AP. An intelligent rapid odour recognition model in discrimination of Helicobacter pylori and other gastrooesophageal isolates in vitro. Biosensors and Bioelectronics, 2000, 15(7–8), 333–42.
Pearce RKB, Hawkes CH and Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Movement Disorders, 1995, 10, 283–7.
Pearson RC, Esiri MM, Hiorns RW, Wilcock GK and Powell TP. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proceedings of the National Academy of Science of the United States of America, 1985, 82(13), 4531–4.
Pearson RCA, Esiri MM, Hiornes RW, Wilcock GK and Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 1985, 82, 4531–4.
Pelissolo A and Bisserbe JC. Dependence on benzodiazepines. Clinical and biological aspects Encephale, 1994, 20(2), 147–57.
Pelosi P, Maremmani C and Muratorio A. Purification of an odorant binding protein from human nasal mucosa. NATO ASI series, 1990, H 39, 125–30.
Penfield W and Perot P. The brain's record of auditory and visual experience. A final summary and discussion. Brain, 1963, 86, 595–696.
Perlman S, Evans G and Afifi A. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. Journal of Experimental Medicine, 1990, 172(4), 1127–32.
Persaud K and Dodd G. Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose. Nature, 1982, 299(5881), 352–5.
Peters G. Multiple sklerose. In: O Lubarsche, F Henke and R Rossle, eds, Handbuch der Speziellen Pathologischen Anatomie und Histologie, Vol XIII. Erkrankungen des Zentralen Nerven Systems. II. Bandtiel A. IV 525–590, 1958.
Pierce JD Jr, Doty RL and Amoore JE. Analysis of position of trial sequence and type of diluent on the detection threshold for phenyl ethyl alcohol using a single staircase method. Perceptual and Motor Skills, 1996, 82, 451–8.
Pilpel Y and Lancet D. The variable and conserved interfaces of modeled olfactory receptor proteins. Protein Science, 1999, 8, 969–77.
Pinching AJ. Clinical testing of olfaction reassessed. Brain, 1977, 100, 377–88.
Plailly J, Bensafi M, Pachot-Clouard M et al. Involvement of right piriform cortex in olfactory familiarity judgments. Neuroimage, 2005, 24(4), 1032–41.
Pletsch PK and Kratz AT. Why do women stop smoking during pregnancy? Cigarettes taste and smell bad. Health Care for Women International, 2004, 25, 671–9.
Poellinger A, Thomas R, Lio P et al. Activation and habituation in olfaction – an fMRI study. Neuroimage, 2001, 13(4), 547–60.
Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECH and Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Annals of Neurology, 2004, 56(2), 173–81.
Potter H and Butters N. An assessment of olfactory deficits in patients with damage to prefrontal cortex. Neuropsychologia, 1980, 18, 621–8.
Price JL. The olfactory system. In: G Paxinos and JK Mai, eds. The Human Nervous System (2nd edition). New York, NY: Academic Press, Inc., 2004, Chapter 32.
Proust M. Remembrance of Things Past. C. K. Scott-Moncrieff and T. Kilmartin, trans. New York, NY: Alfred A. Knoff, 1982.
Pryse-Phillips W. An olfactory reference syndrome. Acta Psychiatrica Scandinavica, 1971, 47(4), 484–509.
Pryse-Phillips W. Disturbance in the sense of smell in psychiatric patients. Proceedings of the Royal Society of Medicine, 1975, 68, 472–4.
Punter PH. Measurement of human olfactory thresholds for several groups of structurally related compounds. Chemical Senses, 1983, 7, 215–35.
Quinn NP, Rossor MN and Marsden CD. Olfactory threshold in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 1987, 50, 88–9.
Rajan R, Clement JP and Bhalla US. Rats smell in stereo. Science, 2006, 311, 666–70.
Rebeck GW and Hyman BT. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease. Neurobiology and Aging, 1993, 14(1), 45–7.
Reinacher M, Bonin J, Narayan O and Scholtissek C. Pathogenesis of neurovirulent influenza – a virus infection of mice. Laboratory Investigation, 1983, 49, 686–92.
Rennie PJ, Gower DB and Holland KT. In-vitro and in-vivo studies of human axillary odor and the cutaneous microflora. British Journal of Dermatology, 1991, 124(6), 596–602.
Rey A. L'Examen Clinique en Psychologie. Paris: Presses Universitaires de France, 1964.
Reyes PF, Deems DA and Suarez MG. Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study. Brain Research Bulletin, 1993, 32, 1–5.
Roalf DR, Turetsky BI, Owzar K et al. Unirhinal olfactory function in schizophrenia patients and first-degree relatives. Journal of Neuropsychiatry and Clinical Neurosciences, 2006, 18, 389–96.
Roberts E. Alzheimer's disease may begin in the nose and may be caused by aluminosilicates. Neurobiology and Aging, 1986, 7, 561–7.
Robertson EG. An examination of the olfactory bulbs in fatal cases of poliomyelitis during the Victorial epidemic of 1937–1938. Medical Journal of Australia, 1940, I, 156–8.
Rochefort C, Gheusi G, Vincent JD and Lledo PM. Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory. Journal of Neuroscience, 2002, 22, 2679–89.
Rolls ET. The functions of the orbitofrontal cortex. Brain and Cognition, 2004, 55(1), 11–29.
Ronnett GV and Snyder SH. Molecular messengers of olfaction. Trends in Neuroscience, 1992, 15, 508–13.
Ronnett GV, Leopold D, Cai X et al. Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Annals of Neurology, 2003, 54(2), 206–18.
Ros Ruiz S, Bernardino de la Serna JI, Peiteado Lopez D and Garcia Puig J. Anosmia as presenting symptom of Churg–Strauss syndrome. Revista Clínica Española, 2003, 203(5), 263–4.
Rosli Y, Breckenridge LJ and Smith RA. An ultrastructural study of age-related changes in mouse olfactory epithelium. Journal of Electron Microscopy, 1999, 48, 77–84.
Ross GW, Petrovitch H, Abbott RD et al. Parkinsonian signs and substantia nigra neuron density in descendents elders without PD. Annals of Neurology, 2004, 56, 532–9.
Ross W, Abbott RD, Petrovitch H et al. Association of olfactory dysfunction with incidental Lewy bodies. Movement Disorders, 2006, 21(12), 2062–7.
Ross W, Petrovitch H, Abbott RD et al. Association of olfactory dysfunction with risk of future Parkinson's disease. Annals of Neurology, 2008, 63(2), 167–73.
Rousselot P, Lois C and Alvarez-Buylla A. Embryonic (PSA) N-CAM reveals chains of migrating neuroblasts between the lateral ventricle and the olfactory bulb of adult mice. Journal of Comparative Neurology, 1994, 351, 51–61.
Rovee CK, Cohen RY and Shlapack W. Life-span stability in olfactory sensitivity. Developmental Psychology, 1975, 11, 311–18.
Royall DR, Chiodo LK, Polk MS and Jaramillo CJ. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology, 2002, 21(2), 68–73.
Royet JP, Hudry J and Zald DH et al. Functional neuroanatomy of different olfactory judgments. Neuroimage, 2001, 13(3), 506–19.
Sabin AB and Olitsky PK. Influence of pathway of infection on pathology of olfactory bulbs in experimental poliomyelitis. Proceedings of the Society for Experimental Biology and Medicine, 1936, 35, 300–1.
Sabin AB. Olfactory bulbs in human poliomyelitis. American Journal of Diseases in Children, 1940, 60, 1313–18.
Sajjadian A, Doty RL, Gutnick D, Chirurgi RJ, Sivak M and Perl D. Olfactory dysfunction in amyotrophic lateral sclerosis. Neurodegeneration, 1994, 3, 153–7.
Sallaz M and Jourdan F. Apomorphine disrupts odor-induced patterns of glomerular activation in the olfactory bulb. Neuroreport, 1992, 3, 833–6.
Sanders MD, Warrington EK, Marshall J and Wieskrantz L. ‘Blindsight’: Vision in a field defect. Lancet, 1974, 1(7860), 707–8.
Sandyk R. Olfactory hallucinations in Parkinson's disease. South African Medical Journal, 1981, 60(25), 950.
Sassoe-Pognetto M and Ottersen OP. Organization of ionotropic glutamate receptors at dendrodendritic synapses in the rat olfactory bulb. Journal of Neuroscience, 2000, 20, 2192–201.
Savic I, Berglund H, Gulyas B and Roland P. Smelling of odorous sex hormone-like compounds causes sex-differentiated hypothalamic activations in humans. Neuron, 2001, 31, 661–8.
Sayek I. The incidence of the inability to smell solutions of potassium cyanide in the rural health center of Ortabereket. Turkish Journal of Pediatrics, 1970, 12(3), 72–5.
Schank JC. Menstrual-cycle variability and measurement: further cause for doubt. Psychoneuroendocrinology, 2000, 25, 837–47.
Schank JC. Problems with dimensionless measurement models of synchrony in biological systems. American Journal of Primatology, 1997, 41, 65–85.
Schechter PJ, Friedewald WT, Bronzert DA et al. Idiopathic hypogeusia: a description of the syndrome and a single blind study with zinc sulfate. International Review of Neurobiology, 1972, 1(Suppl.), 125–40.
Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J and Welsh-Bohmer K. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease. Neurobiology and Aging, 2002, 23, 397–404.
Schiffman SS, Reynolds ML and Young FW. Introduction to Multidimensional Scaling: Theory, Methods, and Applications. Orlando, FL: Academic Press, 1981.
Schlesinger RB. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. Journal of Toxicology and Environmental Health, 1985, 15, 197–214.
Schlitt M, Chronister RB and Whitley RJ. Pathogenesis and pathophysiology of viral infections of the central nervous system. In: WM Scheld, RJ Whitley and DT Durack, eds, Infections of the Central Nervous System. New York, NY: Raven Press, 1991, pp. 7–18.
Schneider RA and Wolf S. Relation of olfactory acuity to nasal membrane function. Journal of Applied Physiology, 1960, 15, 914–20.
Schon F. Involvement of smell and taste in giant cell arteritis. Journal of Neurology, Neurosurgery, and Psychiatry, 1988, 51(12), 1594.
Schultz EW and Gebhardt, LR. Prevention of intranasally inoculated poliomyelitis in monkeys by previous intranasal irrigation with chemical agents. Proceedings of the Society for Experimental Biology and Medicine, 1936, 34, 133–5.
Schultz, EW and Gebhardt LR. Zinc sulfate prophylaxis in poliomyelitis. Journal of the American Medical Association, 1937, 108, 2182–4.
Schwartz BS, Doty RL, Monroe C, Frye R and Barker S. Olfactory function in chemical workers exposed to acrylate and methacrylates vapors. American Journal of Public Health, 1989, 79(5), 613–18.
Schwartz BS, Doty RL, Monroe C, Frye R and Barker S. Olfactory function in chemical workers exposed to acrylate and methacrylates vapors. American Journal of Public Health, 1989, 79(5), 613–18.
Schwartz BS, Ford DP, Bolla KI, Agnew J, Rothman N and Bleecker ML. Solvent-associated decrements in olfactory function in paint manufacturing workers. American Journal of Industrial Medicine, 1990, 18(6), 697–706.
Schwartz BS, Ford DP, Bolla KI, Agnew J, Rothman N and Bleecker ML. Solvent-associated decrements in olfactory function in paint manufacturing workers. American Journal of Industrial Medicine, 1990, 18(6), 697–706.
Scott JW and Scott-Johnson PE. The electroolfactogram: a review of its history and uses. Microscopy Research and Technique, 2002, 58(3), 152–60.
Semb G. The detectability of the odor of butanol. Perception and Psychophysics, 1968, 4, 335–40.
Semchuk KM, Love EJ and Lee RG. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology, 1992, 42(7), 1328–35.
Serizawa S, Miyamichi K, Nakatani H et al. Negative feedback regulation ensures the one receptor–one olfactory neuron rule in mouse. Science, 2003, 302, 2088–94.
Setzer AK and Slotnick B. Odor detection in rats with 3-methylindole-induced reduction of sensory input. Physiology and Behavior, 1998, 65(3), 489–96.
Shackelford J and Pagano JS. Targeting of host-cell ubiquitin pathways by viruses. Essays in Biochemistry, 2005, 41, 139–54.
Shah M, Deeb J, Fernando M et al. Abnormality of taste and smell in Parkinson's disease. Parkinsonism and Related Disorders, 2008, July 5, (Epub ahead of print).
Shah M, Findley LJ, Muhammed N and Hawkes CH. Olfaction is normal in essential tremor and can be used to distinguish it from Parkinson's disease. Movement Disorders, 2005, 20(Suppl. 10), 563 (abstract).
Shannahoff-Khalsa DS, Kennedy B, Yates FE and Ziegler MG. Ultradian rhythms of autonomic, cardiovascular, and neuroendocrine systems are related in humans. American Journal of Physiology, 1996, 270, R873–87.
Shepherd GM. In: GM Shepherd, ed. Neurobiology (3rd edition). Oxford, UK: Oxford University Press, 2004.
Sherer TB, Betarbet R, Testa CM et al. Mechanism of toxicity in rotenone models of Parkinson's disease. Journal of Neuroscience, 2003, 23, 10, 756–64.
Sherman AH, Amoore JE and Weigel V. The pyridine scale for clinical measurement of olfactory threshold: a quantitative re-evaluation. Otolaryngology, Head, and Neck Surgery, 1979, 87(6), 717–33.
Shipley MT. Transport of molecules from nose to brain: transneuronal anterograde and retrograde labelling in the rat olfactory system by wheatgerm agglutin– horseradish peroxidase applied to the nasal epithelium. Brain Research Bulletin, 1985, 15, 129–42.
Siderowf A, Newberg A and Chou KL et al. (99mTc)TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology, 2005, 64(10), 1716–20.
Siegel RK. Cocaine hallucinations. American Journal of Psychiatry, 1978, 135(3), 309–14.
Sienkiewicz-Jarosz H, Scinska A, Kuran W et al. Taste responses in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 2005, 76(1), 40–6.
Silberstein SD, Niknam R, Rozen TD and Young WB. Cluster headache with aura. Neurology, 2000, 11, 54(1), 219–21.
Silveira-Moriyama L, Guedes L, Kingsbury A et al. Olfaction in dardarin/LRRK2 associated Parkinsonism. Movement Disorders, 2007, 22(Suppl. 16), S258.
Silveira-Moriyama L, Williams D, Katzenschlager R and Lees AJ. Pizza, mint and licorice: smell testing in Parkinson's disease in a UK population. Movement Disorders, 2005, 20(Suppl. 10), P471 (abstract).
Silveira-Moriyama L, Williams D, Katzenschlager R and Lees AJ. Pizza, mint, and licorice: smell testing in Parkinson's disease in a UK population. Movement Disorders, 2005, 20(Suppl. 10), P471 (abstract).
Silveira-Moriyama L, Williams DR, Evans AH, Katzenschlager R, Watt H and Lees AJ. A UK comparison of Sniffin' Sticks (SS) and University of Pennsylvania (UPSIT) Smell Identification Tests in Parkinson's disease. Movement Disorders, 2006, 21 (Supplement 15), P814.
Simmen D, Briner HR and Hess K. Screening of olfaction with smell diskettes. Laryngorhinootologie, 1999, 78(3), 125–30.
Singh N, Grewal MS and Austin JH. Familial anosmia. Archives of Neurology, 1970, 22, 40–4.
Singleton A, Gwinn-Hardy K, Sharabi Y et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain, 2004, 127 (Pt 4), 768–72.
Sisodiya SM, Free SL, Williamson KA et al. PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nature Genetics, 2001, 28(3), 214–16.
Sklar PB, Anholt RR and Snyder SH. The odorant-sensitive adenylate cyclase of olfactory receptor cells. Differential stimulation by distinct classes of odorants. Journal of Biological Chemistry, 1986, 261, 15 538–43.
Slotnick B and Bodyak N. Odor discrimination and odor quality perception in rats with disruption of connections between the olfactory epithelium and olfactory bulbs. Journal of Neuroscience, 2002, 22(10), 4205–16.
Smith CAD, Gough AC, Leigh PN et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson' disease. Lancet, 1992, 339, 1375–7.
Smith CG. Age incident of atrophy of olfactory nerves in man. Journal of Comparative Neurology, 1942, 77, 589–94.
Smith DH, Uryu K, Saatman KE, Trojanowski JQ and McIntosh, TK. Protein accumulation in traumatic brain injury. Neuromolecular Medicine, 2003, 4, 59–72.
Smith RS, Doty RL, Burlingame GK and McKeown DA. Smell and taste function in the visually impaired. Perception and Psychophysics, 1993, 54, 649–55.
Smith TD, Bhatnagar KP, Shimp KL et al. Histological definition of the vomeronasal organ in humans and chimpanzees, with a comparison to other primates. Anatomical Record, 2002, 267, 166–76.
Smutzer GS, Doty RL, Arnold SE and Trojanowski JQ. Olfactory system neuropathology in Alzheimer's disease. Parkinson's disease and schizophrenia. In: RL Doty, ed., Handbook of Olfaction and Gustation (second edition). New York, NY: Marcel Dekker, 2003, Chapter 24.
Snyder RD and Drummond PD. Olfaction in migraine. Cephalalgia, 1997, 17(7), 729–32.
Sobel N, Johnson BN, Mainland J and Yousem DM. Functional neuroimaging of human olfaction. In: RL Doty, ed. Handbook of Olfaction and Gustation. New York, NY: Marcel Dekker, 2003, pp. 251–73.
Sobel N, Khan RM, Saltman A, Sullivan EV and Gabrieli JD. The world smells different to each nostril. Nature, 1999, 402(6757), 35.
Sobel N, Khan RM, Saltman A, Sullivan EV and Gabrieli JD. The world smells different to each nostril. Nature, 1999a, 402, 35.
Sobel N, Pabhakaran V, Zhao Z et al. Time course of odorant-induced activation in the human primary olfactory cortex. Journal of Neurophysiology, 2000, 83, 537–51.
Sobel N, Prabhakaran V, Desmond JE et al. Sniffing and smelling: separate subsystems in the human olfactory cortex. Nature, 1998, 392, 282–6.
Sobel N, Prabhakaran V, Hartley CA et al. Blind smell: brain activation induced by an undetected air-borne chemical. Brain, 1999b, 122, 209–17.
Sobel N, Thomason ME, Stappen I et al. An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proceedings of the National Academy of Science of the United States of America, 2001, 98, 4154–9.
Sobin C, Kiley-Brabeck K, Dale K, Monk SH, Khuri J and Karayiorgou M. Olfactory disorder in children with 22q11 deletion syndrome. Pediatrics, 2006, 118(3), e697–703.
Sommer U, Hummel T, Cormann K et al. Detection of presymptomatic Parkinson's disease: combining smell tests transcranial sonography and SPECT. Movement Disorders, 2004, 19(10), 1196–202.
Sorter A, Kim J, Jackman A, Tourbier I, Kaul A and Doty RL. Accuracy of self-report in detecting taste dysfunction. Laryngoscope, 2008, 118, 611–17.
Spiegel AM and Weinstein LS. Inherited diseases involving g proteins and g protein-coupled receptors. Annual Review of Medicine, 2004, 55, 27–39.
Spiegel J, Hellwig D, Mollers MO et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain, 2006, 129(Pt 5), 1188–93.
Spielman AI, Zeng XN, Leyden JJ and Preti G. Proteinaceous precursors of human axillary odor: isolation of two novel odor-binding proteins. Experientia, 1995, 51, 40–7.
Spierings EL, Ranke AH and Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache, 2001, 41(6), 554–8.
Steck-Scott S, Forman MR, Sowell A et al. Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial. International Journal of Cancer, 2004, 112(2), 295–305.
Stegeman CA, Cohen Tervaert JW, de Jong PE and Kallenberg CG. Trimethoprim– sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. New England Journal of Medicine, 1996, 335, 16–20.
Stern K and McClintock MK. Regulation of ovulation by human pheromones. Nature, 1998, 392, 177–9.
Stern MB, Doty RL, Dotti M et al. Olfactory function in Parkinson's disease subtypes. Neurology, 1994, 44, 266–8.
Stevens JC and Marks LE. Cross-modality matching functions generated by magnitude estimation. Perception and Psychophysics, 1980, 27, 379–89.
Stevens JC, Cain WS and Burke RJ. Variability of olfactory thresholds. Chemical Senses, 1988, 13, 643–53.
Stevens JR. Central and peripheral factors in epileptic discharge. Clinical studies. Archives of Neurology, 1962, 7, 330–8.
Stevens SS. The psychophysics of sensory function. American Scientist, 1960, 48, 226–53.
Stiasny-Kolster K, Clever SC, Möller JC, Oertel WH, Mayer G. Olfactory dysfunction in patients with narcolepsy with and without REM sleep behaviour disorder. Brain, 2007, 130(Pt 2), 442–9.
Stiasny-Kolster K, Doerr Y, Moller JC et al. Combination of ‘idiopathic’ REM sleep behavior disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain, 2005, 128(Pt 1), 126–37.
Stott WT, Ramsey JC and McKenna MJ. Absorption of chemical vapors by the upper respiratory tract of rats. In: CS Barrow, ed. Toxicology of the Nasal Passages. Washington, DC: Hemisphere Publishing Corporation, 1986, pp. 191–210.
Strassmann BI. Menstrual synchrony pheromones: cause for doubt. Human Reproduction, 1999, 14, 579–80.
Strassmann BI. The biology of menstruation in Homo sapiens: total lifetime menses, fecundity, and nonsychrony in a natural-fertility population. Current Anthropology, 1997, 38, 123–9.
Stroop WG. Viruses and the olfactory system. In: RL Doty, ed. Handbook of Olfaction and Gustation (1st edition). New York, NY: Marcel Dekker, 1995, pp. 367–93.
Sugiura M, Aiba T, Mori J and Nakai Y. An epidemiological study of postviral olfactory disorder. Acta Otolaryngologica, 1998, 538(Suppl.), 191–6.
Sumner D. Disturbances of the senses of smell and taste after head injuries. In PJ Vinken and GW Bruyn, eds, Handbook of Clinical Neurology, Vol. 24 Injuries of the Brain and Skull Part II. Amsterdam: Elsevier Press, 1976, pp. 1–25.
Sumner D. Disturbances of the senses of smell and taste after head injuries. In: PJ Vinken and GW Bruyn, eds., Handbook of Clinical Neurology. Amsterdam: Elsevier Press, 1976, pp. 1–25.
Swan GE and Carmelli D. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology, 2002, 21(2), 58–67.
Tabert MH, Liu X, Doty RL et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Annals of Neurology, 2005, 58(1), 155–60.
Tabert MH, Steffener J, Albers MMW et al. Validation and optimization of statistical approaches for modeling odorant-induced fMRI signal changes in olfactory-related brain areas. NeuroImage, 2007, 34, 1375–90.
Takagi SF. Human Olfaction. Tokyo: University of Tokyo Press, 1989.
Takahashi T. Seizures induced by odorous stimuli. Clinical Electroencephalography, 1975, 17, 769.
Talamo BR, Rudel R, Kosik KS et al. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature, 1989, 23, 337(6209), 736.
Tanner CM, Goldman SM, Aston DA et al. Smoking and Parkinson's disease in twins. Neurology, 2002, 58(4), 581–8.
Tanner WP Jr and Swets JA. A decision-making theory of visual detection. Psychological Reviews, 1954, 61, 401–9.
Tateyama T, Hummel T, Roscher S, Post H and Kobal G. Relation of olfactory event-related potentials to changes in stimulus concentration. Electroencephalography and Clinical Neurophysiology, 1998, 108, 449–55.
Tennen H, Affleck G and Mendola R. Coping with smell and taste disorders. In: TV Getchell, RL Doty, LM Bartoshuk and Snow JB Jr., eds., Smell and Taste in Health and Disease. New York, NY: Raven Press, 1991, pp. 787–802.
Thaler ER and Hanson CW. Use of an electronic nose to diagnose bacterial sinusitis. American Journal of Rhinology, 2006, 20(2), 170–2.
Tirindelli R, Mucignat-Caretta C and Ryba NJ. Molecular aspects of pheromonal communication via the vomeronasal organ of mammals. Trends in Neurosciences, 1998, 21, 482–6.
Tisdall FF, Brown A, Defries RD, Ross MA and Sellers AH. Nasal spraying as preventive of poliomyelitis. Canadian Public Health Journal, 1937, 28, 431–4.
Tissingh G, Berendse HW, Bergmans P et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Movement Disorders, 2001, 16(1), 41–6.
Tjalve H and Henriksson J. Uptake of metals in the brain via olfactory pathways. Neurotoxicology, 1999, 20, 181–95.
Tjalve H, Henriksson J, Tallkvist, J, Larsson BS and Lindquist NG. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacology & Toxicology, 1996, 79, 347–56.
Tomlinson AH and Esiri MM. Herpes simplex encephalitis: immuno-histological demonstration of spread of virus via olfactory pathways in mice. Journal of Neurological Science, 1983, 60, 473–84.
Toyota B, Kitamura T and Takagi SF. Olfactory Disorders – Olfactometry and Therapy. Tokyo: Igaku-Shoin, 1978.
Trojanowski JQ, Newman PD, Hill WD and Lee VM. Human olfactory epithelium in normal aging Alzheimer's disease and other neurodegenerative disorders. Journal of Comparative Neurology, 1991, 310, 365–76.
Tsai PS and Gill JC. Mechanisms of disease: insights into X-linked and autosomal-dominant Kallman syndrome. National Clinics in Practical Endocrinology and Metabolism, 2006, 2(3), 160–71.
Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N and Dickson DW. Tau pathology in the olfactory bulb correlates with Braak stage Lewy body pathology and apolipoprotein epsilon4. Neuropathology and Applied Neurobiology, 2003, 29(5), 503–10.
Turetsky BI, Moberg PJ, Arnold SE, Doty RL and Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. American Journal of Psychiatry, 2003b, 160(4), 703–8.
Turetsky BI, Moberg PJ, Roalf DR, Arnold SE and Gur RE. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Archives of General Psychiatry, 2003a, 60(12), 1193–200.
Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE and Gur RE. Reduced olfactory bulb volume in patients with schizophrenia. American Journal of Psychiatry, 2000, 157, 828–30.
Turner AP and Magan N. Electronic noses and disease diagnostics. Nature Reviews. Microbiology, 2004, 2(2), 161–6.
Tyas SL, Manfreda J, Strain LA and Montgomery PR. Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. International Journal of Epidemiology, 2001, 30, 590–7.
Tzen KY, Lu CS, Yen TC, Wey SP and Ting G. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1. Journal of Nuclear Medicine, 2001, 42(3), 408–13.
Uchida K, Kihara N, Hashimoto K, Nakayama H and Yamaguchi RT. Age-related histological changes in the canine substantia nigra. Journal of Veterinary Medicine and Science, 2003, 65(2), 179–85.
Vanscheeuwijck PM, Teredesai A and Terpstra PM et al. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food and Chemical Toxicology, 2002, 40, 113–31.
Varney NR and Bushnell D. NeuroSPECT findings in patients with posttraumatic anosmia: a quantitative analysis. Journal of Head Trauma Rehabilitation, 1998, 13(3), 63–72.
Varney NR, Pinkston JB and Wu JC. Quantitative PET findings in patients with posttraumatic anosmia. Journal of Head Trauma Rehabilitation, 2001, 16(3), 253–9.
Varney NR. Prognostic significance of anosmia in patients with closed-head trauma. Journal of Clinical and Experimental Neuropsychology, 1988, 10, 250–4.
Velakoulis D. Olfactory hallucinations. In: W Brewer, D Castle and C Pantelis, eds, Olfaction and the Brain. Cambridge, UK: Cambridge University Press, 2006, pp. 322–33.
Vogt BA, Van Hoesen GW and Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathologica, 1990, 80(6), 581–9.
Vollmecke T and Doty RL. Development of the Picture Identification Test (PIT): a research companion to the University of Pennsylvania Smell Identification Test. Chemical Senses, 1985, 10, 413–14.
von Békésy G. Problems relating psychological and electrophysiological observations in sensory perception. Perspectives in Biology and Medicine, 1968, 11, 179–94.
von Skramlik E. Uber die Lokalisation der Empfindungen bei den niederen Sinnen. Zeitschrift fur Sinnesphysiologie, 1925, 56, 69–140.
Wakabayashi K, Takahashi H, Ohama E and Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathologica, 1990, 79, 581–3.
Walker JC, Kurtz DB, Shore FM, Ogden MW and Reynolds JH. Apparatus for the automated measurement of the responses of humans to odorants. Chemical Senses, 1990, 15, 165–77.
Wang L, Hari, C, Chen L and Jacob T. A new non-invasive method for recording the electro-olfactogram using external electrodes. Clinical Neurophysiology, 2004, 115(7), 1631–40.
Warner MD, Peabody CA and Berger PA. Olfactory deficits and Down's syndrome. Biological Psychiatry, 1988, 23, 836–9.
Weber EH. De Pulsu, Resorptione, Auditu et Tactu: Annotationes Anatomicae et Physiologiae. Leipzig, Germany: Koehler, 1834.
Weiffenbach JM and Fox PC. Odor identification ability among patients with Sjogren's syndrome. Arthritis and Rheumatism, 1993, 36(12), 1752–4.
Weiffenbach JM and McCarthy VP. Olfactory deficits in cystic fibrosis: distribution and severity. Chemical Senses, 1984, 9, 193–9.
Weiskrantz L. The Ferrier Lecture, Outlooks for blindsight: explicit methodologies for implicit processes. Proceedings of the Royal Society London B Biological Science, 1990, 239(1296), 247–78.
Weisman K, Christensen E and Dreyer V. Zinc supplementation in alcoholic cirrhosis: a double-blind clinical trial. Acta Medica Scandinavica, 1979, 205, 361–6.
Welsh JS. Olfactory detection of human bladder cancer by dogs: another cancer detected by “pet scan”. British Medical Journal, 2004, 329(7477), 1286–7.
Wenning GK, Shephard B, Hawkes CH, Petruckevitch A, Lees A and Quinn N. Olfactory function in typical parkinsonian syndromes. Acta Neurologica Scandinavica, 1995a, 91, 247–50.
Wenning GK, Shephard B, Magalhaes M, Hawkes CH and Quinn NP. Olfactory function in multiple system atrophy. Neurodegeneration, 1993, 2, 169–71.
Wenning GK, Shephard BC, Hawkes CH, Lees A and Quinn N. Olfactory function in progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, Neurosurgery and Psychiatry, 1995b, 57, 251–2.
Wenzel BM. Techniques in olfactometry. A critical review of the last one hundred years. Psychological Bulletin, 1948, 45, 231–47.
Werntz DA, Bickford RG, Bloom FE and Shannahoff-Khalsa DS. Alternating cerebral hemispheric activity and the lateralization of autonomic nervous function. Human Neurobiology, 1983, 2, 39–43.
West SE and Doty RL. Influence of epilepsy and temporal lobe resection on olfactory function. Epilepsia, 1995, 36(6), 531–42.
Westervelt HJ, Carvalho J and Duff K. Presentation of Alzheimer's disease in patients with and without olfactory deficits. Archives of Clinical Neuropsychology, 2007, 22(1), 117–22.
Wetter S and Murphy C. Apolipoprotein E epsilon4 positive individuals demonstrate delayed olfactory event-related potentials. Neurobiology and Aging, 2001, 22, 439–47.
Wetter S and Murphy C. Individuals with Down's syndrome demonstrate abnormal olfactory event-related potentials. Clinical Neurophysiology, 1999, 110(9), 1563–9.
Wetter S, Peavy G, Jacobson M, Hamilton J, Salmon D and Murphy C. Olfactory and auditory event-related potentials in Huntington's disease. Neuropsychology, 2005, 19(4), 428–36.
Whissell-Buechy D and Amoore JE. Odor-blindness to musk: simple recessive inheritance. Nature, 1973, 242(5395), 271–3.
Whitten W. Comment on: Pheromones and regulation of ovulation. Nature, 1999, 401(6750), 232–3.
Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD and Gibberd FB. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. Journal of Neurochemistry, 2002, 80(5), 727–35.
Williams DR, de Silva R, Paviour DC et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain, 2005, 128(Pt 6), 1247–58.
Williams H and Pembroke A. Sniffer dogs in the melanoma clinic? Lancet, 1989, 1(8640): 734.
Wilson DA and Stevenson RJ. The fundamental role of memory in olfactory perception. Trends in Neurosciences, 2003, 26, 243–7.
Wilson DA and Sullivan RM. The D2 antagonist spiperone mimics the effects of olfactory deprivation on mitral/tufted cell odor response patterns. Journal of Neuroscience, 1995, 15, 5574–81.
Wilson DA. Comparison of odor receptive field plasticity in the rat olfactory bulb and anterior piriform cortex. Journal of Neurophysiology, 2000, 84, 3036–42.
Wilson HC. A critical review of menstrual synchrony research. Psychoneuroendocrinology, 1992, 17, 565–91.
Wilson HC. Female axillary secretions influence women's menstrual cycles: a critique. Hormones and Behavior, 1987, 21, 536–46.
Wilson RS, Arnold SE, Schneider JA, Tang Y and Bennett DA. The relation of cerebral Alzheimer's disease pathology to odor identification in old age. Journal of Neurology, Neurosurgery and Psychiatry, 2007a, 78(1), 30–5.
Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA and Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Archives of General Psychiatry, 2007b, 64, 802–8.
Winston JS, Gottfried JA, Kilner JM and Dolan RJ. Integrated neural representations of odor intensity and affective valence in human amygdala. Journal of Neuroscience, 2005, 25(39), 8903–7.
Wisniewski KE, Wisniewski HM, and Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Annals of Neurology, 1985, 17, 278–82.
Witt M, Gudziol V, Haehner A, Reichmann H and Hummel T. Nasal mucosa in patients with Parkinson's disease. Chemical Senses, 2006, 31(5), 479–93 (abstract 106).
Wolfensberger M, Schnieper I and Welge-Lussen A. Sniffin' Sticks: a new olfactory test battery. Acta Otolaryngologica, 2000, 120(2), 303–6.
Wright J. A History of Laryngology and Rhinology. Philadelphia, PA: Lea & Febiger, 1914.
Wysocki CJ and Beauchamp GK. Ability to smell androstenone is genetically determined. Proceedings of the Nationall Academy of Science of the United States of America, 1984, 81(15), 4899–902.
Wysocki CJ and Beauchamp GK. Individual differences in olfaction. In: CJ Wysocki and MR Kare, eds. Genetics of Perception and Communications. New York, NY: Marcel Dekker, 1991, pp. 353–73.
Wysocki CJ, Dorries KM and Beauchamp GK. Ability to perceive androstenone can be acquired by ostensibly anosmic people. Proceedings of the National Academy of Science of the United States of America, 1989, 86(20), 7976–8.
Yahr MD, Orosz D and Purohit DP. Co-occurrence of essential tremor and Parkinson's disease: clinical study of a large kindred with autopsy findings. Parkinsonism and Related Disorders, 2003, 9(4), 225–31.
Yamada M, Onodera M, Mizuno Y and Mochizuki H. Neurogenesis in olfactory bulb identified by retroviral labeling in normal and MPTP-treated adult mice. Neuroscience, 2004, 124(1), 173–81.
Yamagishi M, Ishizuka Y and Seki K. Pathology of olfactory mucosa in patients with Alzheimer's disease. Annals of Otology, Rhinology and Laryngology, 1994, 103, 421–7.
Yamamoto K, Ito K and Yamaguchi, M. A family showing smell disturbance and tremor. Japanese Journal of Human Genetics, 1966, 11, 36–8.
Yano Y, Saito R, Yoshida N et al. A new role for expressed pseudogenes as ncRNA: regulation of mRNA stability of its homologous coding gene. Journal of Molecular Medicine, 2004, 82, 414–22.
Yee KK and Wysocki CJ. Odorant exposure increases olfactory sensitivity: olfactory epithelium is implicated. Physiology and Behavior, 2001, 72, 705–11.
Yoshida M. Correlation analysis of detection threshold data for “standard test” odors. Bulletin of the Faculty of Sciences and Engineering of Cho University, 1984, 27, 343–53.
Youngentoub SL, Schwob JE, Saha S, Manglapus G and Jubelt B. Functional consequences following infection of the olfactory system by intranasal infusion of the olfactory bulb line variant (OBLV) of mouse hepatitis strain JHM. Chemical Senses, 2001, 26(8), 953–63.
Yousem DM, Geckle RJ, Bilker W, McKeown DA and Doty RL. MR evaluation of patients with congenital hyposmia or anosmia. American Journal of Roentgenology, 1996b, 166(2), 439–43.
Yousem DM, Geckle RJ, Bilker WB and Doty RL. Olfactory bulb and tract and temporal lobe volumes. Normative data across decades. Annals of the New York Academy of Science, 1998, 855, 546–55.
Yousem DM, Geckle RJ, Bilker WB, Kroger H and Doty RL. Posttraumatic smell loss: relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Academic Radiology, 1999, 6(5), 264–72.
Yousem DM, Geckle RJ, Bilker WB, McKeown DA and Doty RL. Posttraumatic olfactory dysfunction: MR and clinical evaluation. American Journal of Neuroradiology, 1996a, 17(6), 1171–9.
Yousem DM, Maldjian JA, Siddiqi F et al. Gender effects on odor-stimulated functional magnetic resonance imaging. Brain Research, 1999, 818(2), 480–7.
Yousem DM, Oguz KK and Li C. Imaging of the olfactory system. Seminars in Ultrasound CT and MR, 2001, 22(6), 456–72.
Yousem DM, Oguz KK and Li C. Imaging of the olfactory system. Seminars in Ultrasound CT and MR, 2001, 22(6), 456–72.
Yousem DM, Oguz KK, Li C. Imaging of the olfactory system. Seminars in Ultrasound CT MR, 2001, 22(6), 456–72.
Yousem DM, Williams SC, Howard RO et al. Functional MR imaging during odor stimulation: preliminary data. Radiology, 1997, 204, 833–8.
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE and Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Annals of Neurology, 2001, 49(2), 146–54.
Zaborszky L, Carlsen J, Brashear HR and Heimer L. Cholinergic and GABAergaic afferents to the olfactory bulb in the rat with special emphasis on the projection neurons in the nucleus of the horizontal limb of the diagonal band. Journal of Comparative Neurology, 1986, 243, 488–509.
Zald DH and Pardo JV. Emotion, olfaction and the human amygdale: amygdale activation during aversive olfactory stimulation. Proceedings of the National Academy of Science of the United States of America, 1997, 94, 4119–24.
Zald DH and Pardo JV. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proceedings of the Natioanal Academy of Science of the United States of America, 1997, 94(8), 4119–24.
Zatorre RJ and Jones-Gotman M. Human olfactory discrimination after unilateral frontal or temporal lobectomy. Brain, 1991, 114(Pt 1A), 71–84.
Zatorre RJ, Jones-Gotman M, Evans AC and Meyer E. Functional localization and lateralization of human olfactory cortex. Nature, 1992, 360(6402), 339–40.
Zatorre RJ, Jones-Gotman M, Evans AC and Meyer E. Functional localization and lateralization of human olfactory cortex. Nature, 1992, 360(6402), 339–40.
Zelano C, Bensafi M and Porter J et al. Attentional modulation in human primary olfactory cortex. Nature and Neuroscience, 2005, 8, 114–20.
Zeng XN, Leyden JJ, Brand JG, Speilman AI, McGinley KJ and Preti G. An investigation of human apocrine gland secretion for axillary odor precursors. Journal of Chemical Ecology, 1992, 18, 1039–1055.
Zeng XN, Leyden JJ, Lawley HJ, Sawano K, Nohara I and Preti G. Analysis of characteristic odors from human male axillae. Journal of Chemical Ecology, 1991, 17, 1469–91.
Zhao K, Dalton P, Yang GC and Scherer PW. Numerical modeling of turbulent and laminar airflow and odorant transport during sniffing in the human and rat nose. Chemical Senses, 2006, 31, 107–18.
Zhao K, Pribitkin EA, Cowart BJ, Rosen D, Scherer PW and Dalton P. Numerical modeling of nasal obstruction and endoscopic surgical intervention: outcome to airflow and olfaction. American Journal of Rhinology. 2006, 20(3), 308–16.
Zhao K, Scherer PW, Hajiloo SA and Dalton P. Effect of anatomy on human nasal air flow and odorant transport patterns: implications for olfaction. Chemical Senses, 2004, 29, 365–79.
Zijlmans JC, Thijssen HO, Vogels OJ et al. MRI in patients with suspected vascular parkinsonism. Neurology, 1995, 45(12), 2183–8.
Zimmerman HM and Netsky MG. Pathology of multiple sclerosis. Research Publications Association for Research in Nervous and Mental Disease, 1950, 28, 271–312.
Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G and Cazzato G. Olfactory loss in multiple sclerosis. Journal of Neurological Science, 1999, 168(2), 127–30.
Zola E. Les Oeuvres Completes. Correspondence. 1858–1871. Notes et Commentaires de Maurice Leblond. Paris: Renouard, 1928.
Zorzon M, Ukmar M and Bragadin LM et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Multiple Sclerosis, 2000, 6(6), 386–9.
Zucco GM and Negrin NS. Olfactory deficits in Down subjects: a link with Alzheimer disease. Perception and Motor Skills, 1994, 78(2), 627–31.
Zwaardemaker H. L'Odorat. Paris: Doin, 1925 (monograph).
Zwaardemaker H. On measurement of the sense of smell in clinical examination. Lancet, 1889, 1300–2.
Zwaardemaker H. The sense of smell. Acta Otolaryngologica, 1927, 11, 3–15.